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Regulation Of Natural Killer Cell Development And Function By Activating
Receptor Signaling Pathways
Abstract
Natural killer (NK) cells are lymphocytes of the innate immune system that recognize and eliminate virally
infected and transformed cells through their release of cytotoxic granules and production of inflammatory
cytokines. The balance of intracellular signals received through NK cell activating and inhibitory receptors
dictates these functions and generates target cell specificity during development. Many signaling
pathways downstream of activating receptors contribute to these processes, however, what pathways
and what signaling proteins contribute to NK cell development and function are not fully understood
While NK cells do not possess an antigen-specific immunoreceptor, they do express a variety of germlineencoded activating and inhibitory receptors. MHC I-binding inhibitory receptors, including those of the
Ly49 and KIR families, are expressed in a variegated manner, which creates ligand-specific diversity within
the NK cell pool. In this thesis, I demonstrate that signals derived from activating receptors are critical for
induction of Ly49 receptors/KIRs during NK cell development; activation signals through SLP-76
increased the probability of the Ly49 bi-directional Pro1 promoter to transcribe in the forward versus the
reverse direction, leading to stable Ly49 receptor expression and receptor diversity in mature NK cells.
Not only does activation through SLP-76 impact NK cell development, but downstream signaling
pathways also impact NK cell function. Sustained Ca2+ signaling, known as store-operated Ca2+ entry
(SOCE), occurs downstream of NK cell activating receptor engagement. CD8+ T cells require SOCE for
cytokine production and cytotoxicity; however, less is known about its role in NK cells. In this thesis, I use
mice deficient in STIM1/2, which are required for SOCE, to examine the contribution of sustained Ca2+
signaling to NK cell function. Surprisingly, we found that while SOCE is required for NK cell IFNγ
production in an NFAT-dependent manner, NK cell degranulation and tumor rejection in vivo remained
intact in the absence of SOCE. Our data suggest that mouse NK cells utilize different signaling
mechanisms for cytotoxicity compared to other cytotoxic lymphocytes. In summary, NK cell activating
receptor signals and downstream signaling pathways contribute greatly to the development and function
of NK cells, allowing them to effectively eliminate cancer and virally infected cells.
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ABSTRACT
REGULATION OF NATURAL KILLER CELL DEVELOPMENT AND FUNCTION BY
ACTIVATING RECEPTOR SIGNALING PATHWAYS
Jacquelyn E. Freund
Taku Kambayashi
Natural killer (NK) cells are lymphocytes of the innate immune system that
recognize and eliminate virally infected and transformed cells through their release of
cytotoxic granules and production of inflammatory cytokines. The balance of intracellular
signals received through NK cell activating and inhibitory receptors dictates these
functions and generates target cell specificity during development. Many signaling
pathways downstream of activating receptors contribute to these processes, however,
what pathways and what signaling proteins contribute to NK cell development and
function are not fully understood
While NK cells do not possess an antigen-specific immunoreceptor, they do
express a variety of germline-encoded activating and inhibitory receptors.

MHC I-

binding inhibitory receptors, including those of the Ly49 and KIR families, are expressed
in a variegated manner, which creates ligand-specific diversity within the NK cell pool. In
this thesis, I demonstrate that signals derived from activating receptors are critical for
induction of Ly49 receptors/KIRs during NK cell development; activation signals through
SLP-76 increased the probability of the Ly49 bi-directional Pro1 promoter to transcribe in
the forward versus the reverse direction, leading to stable Ly49 receptor expression and
receptor diversity in mature NK cells.
Not only does activation through SLP-76 impact NK cell development, but
vii

downstream signaling pathways also impact NK cell function. Sustained Ca2+ signaling,
known as store-operated Ca2+ entry (SOCE), occurs downstream of NK cell activating
receptor engagement. CD8+ T cells require SOCE for cytokine production and
cytotoxicity; however, less is known about its role in NK cells. In this thesis, I use mice
deficient in STIM1/2, which are required for SOCE, to examine the contribution of
sustained Ca2+ signaling to NK cell function. Surprisingly, we found that while SOCE is
required for NK cell IFNγ production in an NFAT-dependent manner, NK cell
degranulation and tumor rejection in vivo remained intact in the absence of SOCE. Our
data suggest that mouse NK cells utilize different signaling mechanisms for cytotoxicity
compared to other cytotoxic lymphocytes.

In summary, NK cell activating receptor

signals and downstream signaling pathways contribute greatly to the development and
function of NK cells, allowing them to effectively eliminate cancer and virally infected
cells.
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CHAPTER I: Introduction
Natural Killer Cells & The Immune System
The general purpose of the mammalian immune system is to protect the body
from foreign invaders. The term foreign invaders can refer to multiple entities, including
inorganic materials, bodily fluids of another mammal, pollen from a daffodil, and
pathogens such as bacteria, fungi, and viruses that can be disseminated through food,
air particles, or liquid. The mammalian immune system has developed a complex yet
comprehensive process of protecting the body and maintaining homeostasis. To do this,
it uses a two-armed system: the innate immune arm and the adaptive immune arm.
Both arms share multiple properties, but each has unique features in its execution. The
immune system’s objective is to identify “self” versus “non-self”, and cells of the innate
and adaptive immune system approach this objective differently, using a system of
checks and balances to ensure that non-self entitles are removed 1.
The responses generated by the innate immune system are largely non-specific.
Unlike the adaptive system, the innate immune system is not activated by antigenspecific receptors, but rather through the recognition of conserved features on “non-self”,
or foreign, entities. Cells of the innate immune system include macrophages, dendritic
cells, neutrophils, mast cells, and natural killer cells

1,2

. The kinetics of the innate

immune system during an immune response are rapid. These cells are first responders,
as they patrol barrier surfaces such as the skin and mucosa. Furthermore, they are
important cells for recognizing and often eliminating foreign threats to the body, despite
responding in a relatively similar manner to different kinds of foreign threats. Often
times, while this response is critical for the control of the foreign invader, clearance fails
1

to occur. In that case, the innate immune system provides helper signals to recruit cells
of the adaptive immune system to eliminate the biological threat 1,2.
Cells of the adaptive immune system are characterized differently than those of
the innate immune system because they undergo genetic recombination of cell
membrane receptors that are required for the recognition of specific antigens. The two
cell types of the adaptive immune system are B and T-lymphocytes. Through a
developmental and activation-based process, these cells create antigen-specific
recognition receptors to particular proteins or antigens.

Therefore, following general

activation from the innate immune system, B or T cells specific to the foreign antigen
have ample time to clonally expand and eliminate the threat. What is even more unique
about the adaptive immune response is its ability to create memory

3,4

. These antigen-

specific lymphocytes can persist through the lifespan of an organism and remember the
original threat in case it re-appears later in life.
A downside of this system is that mammals have evolved so rapidly that foreign
invaders are no longer the only threat the immune system must encounter. In fact, the
immune system is imperative for the fight against cancer, which is considered to be
“altered self”. In an elegant attempt to eliminate “non-self” and “altered-self”, adaptive
immune cells need to recognize “altered-self” antigens to be able to discriminate “self”
from “non-self” or altered-self”. Because of this need to recognize and differentiate “self”
versus “non- or altered-self”, the immune system has the potential to misdirect its
attacks, which results in autoimmunity, the immune system’s destruction of “self”.
Natural killer (NK) cells are cells of the innate immune system, as they do not
possess a genetically re-arranged antigen-specific receptor. NK cells comprise between
2

5-15% of peripheral blood lymphocytes, but also reside in the bone marrow, liver,
spleen, uterus, lungs, and secondary lymphoid organs. NK cells were first described in
the 1970s as large granular lymphocytes with the ability to spontaneously kill certain
tumor cell lines 5. NK cells have been described as the innate counterpart of the CD8+ Tcell, the cytotoxic lymphocyte, because NK cells and CD8+ T-cells utilize similar
mechanisms to eliminate biological threats. Yet unlike CD8+ T-cells, NK cells express a
myriad of germline encoded receptors that combinatorially create specificity towards
“non- or altered-self” antigens 5,6.
Not only could NK cells eliminate tumor cells, but also it was discovered early on
that an F1 generation of mice between two inbred parental mouse strains were unable to
accept bone marrow grafts from the parental generation. Researchers determined that
the major histocompatibility I protein complex (MHC-I) was involved, but that it was not
T-cell mediated

7

. This defied the previously established rules of bone marrow

transplantation. Both parental MHC-I molecules were expressed in the F1 mouse, yet
the bone marrow graft was still rejected. This novel finding helped transform the theory
that the immune system’s role was to only eliminate “non-self”, and an NK cell’s ability to
eliminate parental tissue lacking a specific MHC-I molecule led to the concept known as
the “missing-self hypothesis” 8. This process is unique to NK cells and is imperative for
NK cell clearance of cancerous malignancies and viral infections. While the combination
of NK cell receptors creates NK cell specificity against “non- and altered-self”, the fact
that an NK cell can express so many of these receptors individually and in combination
allows them to have a more flexible response to a stimulus than a CD8+ T cell. Because
of these characteristics, NK cells have not been shown to cause overt autoimmunity.

3

NK cell development and function interweave with each other: NK development
affects function and NK cell function impacts development.

One aspect of cellular

biology that impacts both equally are the intracellular signaling pathways employed by
NK cells. While much is already known about signaling in both NK cell development and
function, key questions remain as to the contributions of intracellular signaling in specific
developmental processes and function. Specifically, what signals does an NK cell need
to express its large repertoire of germline encoded receptors? If there are so many, do
different receptors utilize different signals from the NK cell or the environment? Lastly,
do all of the signaling proteins downstream of the MHC-I binding NK cell receptors or
activating receptors contribute to NK cell function against cancer or virally infected cells?
My thesis work addresses these very broad questions by exploring the regulation of NK
cell development and function through activating receptor-signaling pathways.

Natural Killer Cell Development
Hematopoiesis to Mature NK Cell
Both human and murine NK cells begin development in the bone marrow,
deriving from hematopoietic stem cells (HSCs) and the subsequent common lymphoid
progenitors (CLP)

9,10

. The following description of NK cell development is focused on

murine NK cells. NK cell commitment requires the up-regulation of the interleukin (IL)-15
receptor beta chain (CD122), as IL-15 is required for NK cell differentiation and survival.
The up-regulation of CD122 and the lack of lineage markers designated for other cell
types marks the NK precursor stage (pNK), which is defined by the following cell surface
phenotype:

Lin-CD122+NK1.1-DX5-

11

. Furthermore, IL-15 has been shown to be
4

important for cytokine priming of resting NK cells, and dendritic cells and monocytes
produce this IL-15

12-14

. Mice deficient in IL-15 or IL-15 signaling components, such as

janus kinase 3 (JAK3), have reduced numbers of NK cells

10,15

, whereas NK cells from

mice deficient in other gamma chain-based cytokines (e.g. IL-2, IL-4, IL-7) have normal
NK cell numbers and NK cell differentiation

16

. Precursor NK (pNK) cells do not yet

express markers of NK cell specificity, but moreover, they do not express markers of Tor B-cell specificity (CD3 or CD19). The NK cell activating receptors NKG2D and 2B4
are expressed on pNK cells, but these receptors are not NK cell specific 16.
The subsequent stage of murine NK cell development is the immature bone
marrow NK cell (iNK). This stage of development is marked by the acquisition of NK cell
specific membrane proteins such as activating receptors NK1.1, NKp46, and the
inhibitory receptor heterodimer CD94/NKG2A. At this stage, NK cells begin to acquire of
a family of C-type lectin molecules—the Ly49 receptors. NK cells complete their
maturation in both the bone marrow and the spleen with the up-regulation of the integrin
CD49b, also known as DX5, and the further expression of Ly49 family members

6,17

.

These are referred to as mature NK cells (mNK). The factors defining the progression
from pNK to mNK cell have not been fully elucidated, but an iNK cell can be identified by
its lack of the complete phenotypic and functional characteristics of mNKs. iNK cells
have limited (or completely lack) Ly49 receptors and DX5 expression

17

. The acquisition

of Ly49 receptors is discussed in more detail in a later introductory section.
Once a mature NK cell leaves the bone marrow to circulate to other organs, its
maturation is not necessarily complete. Splenic NK cells, commonly referred to as
conventional NK cells, alter their expression of the cell surface proteins CD11b and
CD27.

A four-stage developmental process has been described where NK cells
5

transition through the following stages: CD27-CD11b- (least mature) à CD27+CD11b-à
CD27+CD11b+à CD27-CD11b+ (most mature)18. From adoptive transfer experiments,
most mature NK cells derive from the previously described stage of development and
express higher levels of granzyme B, CD43, and activating/inhibitor receptors 18.

Factors Influencing NK Cell Development
Biological factors from the NK cell’s environment, DNA transcription factors, and
intracellular signaling pathways play an important role in NK cell development. For
example, flt-3 ligand (Flt3L) and the lymphotoxin-beta receptor (LTβR) are vital for NK
cell generation. Absence of Flt3 in mice negatively impacts NK cell numbers. Flt3 has
been shown to induce CD122 expression, which makes NK cells responsive to IL-15 or
IL-2. Furthermore, HSCs from a wild-type (WT) control mouse transferred into a LTβRdeficient mouse cannot support NK cell generation due to defects in the stromal cell
compartment 19. Signals delivered to NK progenitors via the bone marrow stroma and IL15 are sufficient to support both NK cell survival and Ly49 receptor expression

20

. In fact,

in an in vitro culture system in which bone marrow NK progenitors were cultured on bone
marrow stromal cells, stromal cells lacking MHC- I (β2m-/- stroma) induced Ly49G2
expression on Ly49A+-expressing transgenic progenitors over H-2d stromal cells (MHC-I
ligand for Ly49A and Ly49G2)

21

. This suggests that the lack of stromal MHC-I is quite

important for Ly49 acquisition
When it comes to transcription factors, the balance of Eomes and T-bet
expression is as critical for NK cells as it is for T-cells. iNKs express T-bet and the death
ligand TRAIL

22

. T-bet is required for the stabilization of the TRAIL+ iNK cell phenotype
6

which are DX5-. The T-bet transcriptional partner, Eomes, is required for the generation
of DX5+ NK cells. In the absence of Eomes (Eomesfl/fl-VavCre+ mice), NK cells reverted
to a more “immature” TRAIL+ state 22. TRAIL positivity correlated with the developmental
stages for splenic maturation described by Chissone; CD27hiCD11blo iNKs are TRAIL+
and CD27loCD11bhi NKs were DX5+ and Eomes+ 23.
Lastly, like T-cell development, which requires signaling inputs downstream of
the T-cell receptor (TCR), NK cells utilize a similar signaling cascade downstream of
their activating receptors. The use of major signaling proteins has been studied in NK
cell development. It was found that NK cells develop normally in mice deficient in SykZAP70, DNAX-activating protein of 10 kDa (DAP10), and SAP/Fyn

24-26

. T cells require

signaling pathways proximal to the TCR for development so this data suggests that NK
cells do not require them or utilize redundant pathways.

A distal signaling protein

required for T-cell development, SLP-76, is also dispensable for the generation of bone
marrow and splenic NK cells

27,28

. Slp-76 knock-out (KO) mice have increased numbers

and percentages of NK cells (thought to be due to the homeostatic proliferation of cells
in the absence of T-cells), which suggests that activating signaling pathways are not
required for NK cell (CD3-NK1.1+ NKp46+DX5+) generation, but may have other
consequences 27-29.
Ly49 Receptors
Ly49 receptors are NK cell specific receptors that play a critical role in helping
shape NK cell substrate specificity. These receptors are only found in mice, but humans
have functional orthologues known as killer immunoglobulin-like receptors (KIRs). The
majority of Ly49 receptors expressed on NK cells have an inhibitory function. When an
7

NK cell gets activated, Ly49 receptors bind to their ligand, MHC-I, to inhibit NK cell
function. These receptors mediate “missing-self recognition”, which as pointed out earlier
is a major function of NK cells.
Ly49 receptors are homodimeric type II C-lectin proteins. They are located in the
NK cell gene cluster on mouse chromosome 6 and encoded by the Klra gene

30

. There

are 15 Ly49 receptor genes in the C57BL/6 mouse strain, which is the most common
mouse strain for NK cell research, but not all are expressed as protein on the cell
surface

30,31

. Since, Ly49 receptors bind to specific haplotypes of MHC-I, thus not all

Ly49 receptors expressed in a specific mouse strain bind to “self” MHC

32

. Other

commonly studied mouse strains have different numbers and genetic variants of Ly49
receptors, so as a family Ly49 receptors are polymorphic and polygenic. The receptors
are germline encoded and do not undergo DNA re-arrangement to generate specificity.
Nonetheless, NK cells utilize the Ly49 receptor repertoire to help dictate function.
Evolutionarily, this system of Ly49 polymorphism and polygeneicity was probably
pathogen-driven. Because the immune system has evolved over time to survive despite
debilitating infectious agents and each species fails to express a single specificityexpressing cell to fight off foreign antigens, each species had to create a combinatorial
receptor repertoire to survive.
The Ly49 family of receptors possesses inhibitory and activating receptors, and
is critical in “missing-self recognition”

8,33,34

. Two Ly49 receptors (Ly49d,h) encode

activating receptors and the remainder are inhibitory (Ly49q,e,f,I,g,c,a)

35

. Activating

receptors Ly49D and Ly49H signal through the adaptor protein DAP12, which has an
immunoreceptor tyrosine-based activation motif (ITAM) and initiates a phosphorylation
cascade of downstream tyrosine kinases
8

36,37

. Inhibitory Ly49 receptors possess

immunoreceptor tyrosine inhibitory motifs (ITIMs) in their cytoplasmic domains. ITIMs
are phosphorylated following NK cell activation, and recruit SH2-domain containing
protein tyrosine phosphatases such as SHP1 to shut down activation-derived signals 38.
Ly49 receptor expression commences at the iNK cell stage; receptors are
acquired in a particular order until maturation is complete around 8 weeks of age. From
that point on, Ly49 receptor expression is fixed; further expression is not acquired or lost
from this point on

17,39

. Ly49s are expressed heterogeneously and in a seemingly

stochastic manner on an NK cell’s surface

40

. NK cells express up to 6 different Ly49

receptors at the same time, but most range in the 2-3 overlapping receptors per cell

40

.

Lastly, Ly49s are not the only inhibitory receptors expressed on NK cells, just as Ly49D
and Ly49H are not the only activating receptors. Heterodimers of CD94 and NKG2
(CD94/NKG2) can recognize non-classical class I molecule Qa1, and can deliver
inhibitory or activating signals depending on which NKG2 chain attaches 41.
Ly49 receptors are regulated both at the transcriptional and epigenetic level
(Appendix I). The promoter regions of Ly49 genes are active and cis-acting transcription
factors are responsible for protein expression. Ly49 genes have two promoter regions,
but lack any type of enhancer elements

42

. Pro-2 is the promoter region directly

upstream of transcriptional start site in adult NK cells. In 2001, it was found that that
Ly49G contained a further upstream regulatory promoter region that was only active in
immature bone marrow NK cells. This region was coined Pro-1 and is bi-directional,
meaning it transcribes downstream off one strand of DNA and transcribes in reverse off
of the opposite strand. Forward transcription off the Pro-1 promoter correlated with gene
expression, while reverse transcription resulted in no Ly49G protein expression
Pro-1element was also found to be important for Ly49A
9

44

.

43

. A

This probabilistic switch contains many transcription factor-binding sites that
were discovered to overlap (e.g. Ets-1, NFκB, AML-1, C/EBP). Simultaneous disruption
of both the Ets-1 (top strand) and NFκB (bottom strand) sites on the forward or reverse
strands resulted in decreased forward and reverse transcription, which was found to be
totally dependent on Ets-1. AML-1 site mutation (bottom strand) also decreased
transcription in both directions.

Interestingly, NFκB site mutation on the top strand

stopped reverse transcription, and disruption of the NFκB site on the bottom strand
abrogated reverse and decreased forward Ly49 transcription. This might suggest that
NFκB might be crucial for reverse transcription or plays opposing roles depending on
binding site location. Furthermore, of the 3 C/EBP sites on the top DNA strand, the first
two may interfere with the TATA box of the promoter, so competition between C/EBP
and TATA binding protein (TBP) for binding would interfere with forward transcription 45.
Anderson et al, suggest that in immature NK cells, Pro-2 chromatin is in a closed
state, and the early development transcription factors mentioned above direct the
probabilistic switch, Pro-1

45

. This may remove a suppressor complex from binding to

Pro-2. Consequently when Pro-2 chromatin opens, the transcription factors required for
this site are able to bind

45

. Epigenetic regulation (e.g. DNA methylation, histone

acetylation) has been shown to play a role at the Pro-1 and Pro-2 Ly49 promoters. KIR
genes have CpG islands, where the cytosine/guanine density is higher than rest of the
genome, that are highly methylated. Promoter regions of Ly49s have a limited number of
CpG islands, but it is not the quantity that necessarily matters, as a single methylated
CpG can be functionally important. It was found that Ly49A and Ly49C expression
correlated with an un-methylated Pro-2 region; Ly49A and Ly49C non-expressing NK
cells have highly methylated Pro-2 regions. Furthermore, Ly49A Pro-2 was highly
10

methylated in primary fetal NK cells, where the only Ly49 receptor expressed is Ly49e.
Lastly DNA methylation of Ly49A Pro-2 correlated with histone acetylation. In Ly49AEL4 cells, Ly49A Pro-2 remained un-methylated, and it had enriched histone 3 lysine-9
(H3K9) acetylation, a mark of open chromatin 46.
Although inhibitory Ly49 receptors aid in the process of dampening an NK cell
response, their expression on an NK cell is required for optimal NK cell activation as
well. Ly49 receptors play an important role in the education of NK cells---the education
that teaches them “self” from “non-self” or “altered-self”. This education process also
dictates the threshold of signaling an NK cell must achieve to be activated or
homeostatically dormant. While NK cell education will be discussed in more detail in a
later section, there is both positive and negative evidence to suggest that expression of
self-MHC-I binding inhibitory receptors are critical in the clearance of cancer. For
example, self-MHC-I binding KIR receptors (the human equivalent of Ly49 receptors) are
detrimental in human neuroblastoma. Neuroblastoma cells express high levels of MHC-I,
so self-KIRs are inhibited from killing the tumor. KIR blockade is being tested as a viable
therapeutic option for neuroblastoma patients. On the other hand, mice lacking Ly49
receptors and NKG2/CD94 (NKC KD mice) have accelerated solid tumor growth. These
mice undergo MHC-I specific immunoediting, in which both H-2Kb and H-2Db expression
is decreased in tumors of NKC KD mice, but other markers of stress ligands, such as
Rae-1 and Mult1 (NKG2D ligands) are unaffected 47.
Ly49 receptors do not only play an important part in recognizing malignant cells,
but they can also be important in the NK cell mediated clearance of virally infected cells.
In C57BL/6 mice, NK cells express Ly49H. This activating Ly49 does not recognize
MHC-I. Instead its ligand is the m157 protein of mouse cytomegalovirus (MCMV).
11

Therefore, C57BL/6 NK cells are resistant to this specific virus as their NK cells can
effectively eliminate cells infected with the m157 protein. Other mouse strains that do not
express Ly49H are highly susceptible to MCMV. Similar to the role of Ly49s in cancer,
there are conflicting reports as to the importance of Ly49H to MCMV clearance. Ly49H+
NK cells are specific for MCMV-m157, but a report by Orr, et al, provided data to support
the idea that Ly49R- NK cells are responsible for the killing of m157-MCMV infected
cells48.
Killer Immunoglobulin-like Receptors
Human killer immunoglobulin-like receptors (KIRs) are the functional orthologues
of Ly49 receptors. Like Ly49 receptors, human KIRs prevent NK cell mediated killing of
normal cells, whereas distressed cells with decreased or absent MHC-I are susceptible
to NK cell killing. KIRs are functionally similar to Ly49 receptors, yet instead of being Ctype lectin proteins, KIRs possess extracellular immunoglobulin domains and have
specificity towards HLA allotypes 49.
KIRs are polymorphic. There are multiple inhibitory and activating KIRs in the
human population. Inhibitory KIRs have long cytoplasmic domains containing two ITIMs
(KIR-L) and two extracellular immunoglobulin (Ig) domains. Activating KIRs (KIR-S) have
shorter cytoplasmic domains, which lack ITIMs and instead pair with DAP12, the
activating ITAM-containing adaptor protein. Generally, for almost every KIR-L there is a
KIR-S. Although most of the ligands have been determined, there is still promiscuity in
KIR binding and some ligands have not been fully defined. KIRs are up-regulated during
human NK cell development and are expressed in a variegated pattern.

12

KIRs are also transcriptionally regulated similarly to Ly49 receptors. Like the
Ly49s, there is a high level of promoter sequence homology between individual KIRs.
KIRs also possess two upstream promoter regions, one that is important for stable KIR
expression in mature NK cells and another that is a bi-directional promoter, like the Ly49
Pro-1. This acts as a transcriptional switch for KIR expression. A major difference
between KIRs and Ly49s is the location of the bi-directional switch. For KIRs, it is the
proximal promoter rather than the distal. The regulation of KIR expression from the
proximal and distal regions might be very different than that of Ly49 receptors, as
simultaneous activity of the distal sense strand and the proximal anti-sense strand may
lead to the production of a dsRNA.

This would be impossible for Ly49 receptors

because of the organization of the promoter regions. It has been suggested that this
dsRNA may be important for silencing the KIR locus through DNA methylation, as silent
KIRs are methylated and expressed KIRs are hypo-methylated 50.
The modulation of KIR expression in treating hematological malignancies has
been of interest to clinicians in the last decade, and there have been promising results in
the use of KIR therapy in acute myeloid leukemia (AML) and multiple myeloma (MM). In
particular, KIR mismatch following or in the absence of allo-hematopoietic stem cell
transplantation has resulted in the clearance of tumor cells. The KIRs do not find or
recognize their MHC-I ligand, and therefore, are generally uninhibited. These NK cells
thus kill the cancer cells. This therapy, as well as KIR-blockade pharmacologics, is
currently in clinical trials.

Furthermore, NK cell therapies that up-regulate NK cell

activation markers are being developed for NK cell based treatment options 49.
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Natural Killer Cell Activation
Activating Receptors and Signaling
NK cells eliminate “non-self” or “altered self”, such as malignant tumors or virally
infected cells, by cell-mediated cytotoxicity or through the controlled production of
inflammatory cytokines. Cell-mediated cytotoxicity is the exocytosis of cytotoxic granules
that contain perforin, granzymes, and Fas ligand. The most common inflammatory
cytokine produced by NK cells is interferon-gamma (IFNγ), but NK cells can also secrete
tumor necrosis factor alpha (TNFα) and granulocyte macrophage stimulating colony
factor (GM-CSF). These effector functions are initiated through a process known as NK
cell activation. NK cells are primarily activated through the engagement of activation
receptors on their cell surface. Similar to TCR activation, this initiates a phosphorylation
cascade of kinases and adaptor molecules, leading to the activation of distal secondary
messengers diacylglycerol (DAG) and inositol triphosphate (IP3). NK cells can also be
primed for activation or activated directly by cytokines, which will only be briefly
discussed in this introduction 51.
NK cells uniformly express a plethora of activating receptors and all signal
through diverse, but well-characterized signaling pathways. Multiple receptors signal
through ITAMs, such as NK1.1, FcRγIIIa (CD16), Ly49H, Ly49D and the natural
cytotoxicity receptors (NKp46, NKp30, NKp44). There are also receptors that signal
through non-ITAMs, such as NKG2D, 2B4, CD2, and DNAM-1. NK1.1 and CD16 utilize
the ITAM-bearing FCεRIγ adaptor. Natural cytotoxicity receptors, such as NKp46, use
CD3ζ chain ITAMs, and Ly49D/H link up with the adaptor DAP12 for phosphorylation of
the single ITAM motif. Upon engagement, ITAMs are tyrosine phosphorylated on their
14

cytoplasmic tails by Src family kinases. This recruits Syk family kinases, such as ZAP70, which phosphorylate the downstream molecules LAT1/LAT2. LAT1/LAT2 bind to the
signaling adaptor SLP-76 and SLP-76 phosphorylation leads to the cleavage of
phospholipase C gamma (PLCγ) into DAG and IP3 51,52.
The two major non-ITAM receptors are NKG2D and CD244. NKG2D is
expressed in both mice and humans and pairs with either the DAP10 or DAP12 signaling
adaptor. DAP10 expresses YNIM signaling motifs on its cytoplasmic tail and DAP12
signals through ITAMs. The long form of NKG2D, NKG2D-L, associates with DAP10 in
resting murine NK cells. YNIM motifs are phosphorylated by Src family kinases upon
NKG2D ligation with cognate ligand. Unlike ITAM phosphorylation, which activates Syk
kinases, NKG2D may directly recruit Grb2, Vav1, or PI3K

53,54

. A shorter, spliced

alternative of NKG2D, NKG2D-s, associates with DAP10 and DAP12. In fact following
IL-2 or polyI:C activation of NK cells, NKG2D-s is the primary transcribed isoform of
NKG2D, therefore both the ITAM-mediated signaling and PI3K signaling occur

55

.

NKG2D ligands are expressed at low levels in both mice and humans in different
tissues, but they are heavily up-regulated following viral infection and cellular
transformation as a result of cellular stress. The major ligands are the Rae1 family of
proteins, MULT-1 and MIC A/C.

These ligands resemble MHC-I proteins in their

structure 56.
CD244, also known as 2B4, is expressed on all NK cells and associates with the
SLAM-associated protein (SAP) adaptor. 2B4 binds to CD48, which is expressed on all
hematopoietic cells in mice and humans. Upon activation of 2B4, Src famiy kinases
phosphorylate immunoreceptor tyrosine-based switch motifs (ITSM) that recruit SAP and
the Src kinase Fyn.

Vav1 and PLCγ2 are also phosphorylated downstream of 2B4
15

activation. While it is thought that 2B4 ligation on its own is sufficient for activation,
evidence has also suggested that 2B4 acts as a co-receptor. For example, NKG2D and
2B4 may operate together to induce cytotoxicity against target cells

57

. Additionally, 2B4

may have different forms, one being inhibitory and one being activating.

In 1999,

evidence emerged that a short form, 2B4-S, mediated lysis of p815 tumor cells while a
long form, 2B4-L, led to the inhibition of that killing 58.
Distal Secondary Messengers: DAG & IP3
Although initially described as being dispensable for NK cell activation in IL-2expanded splenocyte cultures

27,59

, subsequent studies have shown that SH2 domain

containing leukocyte protein of 76kDa, SLP-76, is indeed critical for signal transduction
downstream of multiple NK cell activating receptors
substrate of the tyrosine kinase ZAP-70

61,62

29,60

. SLP-76 was discovered to be a

and, furthermore, was found to be a critical

signaling protein for T cell development, education, and activation

63,64

. It is an adaptor

protein with multiple domains specific for protein kinase or membrane docking proteins.
In particular, PLCγ (NK cells preferentially use PLCγ2 over PLCγ152) binds to the proline
rich

region

of

SLP-76,

and

PLCγ

activation

results

in

the

hydrolysis

of

phosphatidylinositol 4,5-bisphosphate (PIP2) into DAG and IP3. Disruption of SLP-76 in
T cells results in reduced IP3 generation and calcium (Ca2+) flux. Correspondingly SLP76 deficient T cells have decreased ERK and NFAT activation due to the loss of DAG
and IP3-mediated signaling 64.
DAG is a direct activator of protein kinase C (PKC). Most work on DAG has been
done on T cells or mast cells, but one major study of DAG and NK cells was recently
published from our lab

65

. For example, mice with enhanced DAG signaling (DGKζ KO
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mice) have increased T cell proliferation following TCR stimulation, are more likely to
respond against LCMV infection, and have increased markers of activation

66

. DAG is

important for the polarization of cytotoxic T cell microtubule-organizing center, which
organizes the immune synapse, and is also critical for T cell cytotoxicity against target
cells

67

. Recently, NK cells with increased DAG signaling (from DGKζ KO mice) were

found to be hyper-functional, showing increased degranulation and IFNγ production
following NK cell stimulation, and enhanced killing of tumor cells via an ERK-dependent
mechanism 65.
IP3, the other signaling arm of PLCγ pathway, is the second messenger required
for sustained Ca2+ mobilization from the extracellular environment into cellular
cytoplasm. IP3 binds to IP3R on the membrane of the endoplasmic reticulum (ER), which
signals the ER to empty its intracellular stores of Ca2+into the cytoplasm. This efflux of
Ca2+into the cytoplasm causes the stromal interacting molecules 1 & 2 (STIM1/STIM2),
which act as ER Ca2+sensors, to oligomerize and bind to the cellular membrane ORAI
proteins, or what is referred to as the CRAC channel. It is through the CRAC channel,
which is highly Ca2+specific, that Ca2+ can mobilize into the cell very transiently. It is the
continual stimulation of this pathway (which often acts as a positive feed-forward loop)
that accounts for sustained Ca2+ signaling. Ca2+ signaling via this manner is also known
as store-operated Ca2+ entry (SOCE), and is very important for maintaining local Ca2+
domains, activating a host of transcription factors, specifically NFAT via calcineurin

68-71

.

NK cells mediate SOCE following stimulation of a variety of NK cell activating receptors
72

, but Ca2+ signaling has only been explored lightly in NK cells and is still considered

unexplored territory.
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Functional Outcomes & Flexibility of NK cell Responses
NK cells, like their T-cell adaptive counterparts, are critical in the clearance of
“non-self” or “altered-self”, and they respond to such target cells through the intracellular
signaling pathways downstream of their activating and inhibitory receptors. But critical
questions remain in the NK cell field about how exactly this response is achieved,
especially with the diverse assortment of both inhibitory and activating receptors an NK
cell can express.

T-cells learn their peripheral response in the thymus, an organ

dedicated to their education. Unlike T-cells, NK cells do not develop in an organ solely
devoted to fostering NK cell education or development. NK cells develop in the bone
marrow, and over time, acquire their activating and inhibitory receptors, leaving it unclear
how NK cell tolerance and NK cell effector response to targets are achieved.
There are three principal theories for how NK cells are educated:

licensing,

disarming, and tuning (rheostat model). Licensing proposes that NK cells acquire
functional competence through the acquisition of inhibitory receptors. The disarming
hypothesis proposes that lack of MHC-I expression renders NK cells anergic or hyporesponsive. In 2005, research from Wayne Yokoyama’s laboratory found that NK cells
expressing a self-binding Ly49 receptor (licensed) are more responsive to activating
receptor stimulation than NK cells not expressing a self-binding Ly49 (unlicensed).
Ly49C+ NK cells taken from a C57BL/6 animal (H2b) readily produce more IFNγ than
Ly49A+ NK cells from the same mouse following NK1.1 stimulation

33

. Ly49C and Ly49A

bind H2b and H2d respectively. The licensing hypothesis has been challenged. For
example, in 2010 a Nature Immunology paper from Lewis Lanier’s lab demonstrated that
unlicensed Ly49H+ (which recognize the m157 protein of MCMV) NK cells are
responsible for the elimination of m157-expressing target cells. These NK cells secrete
18

more IFNγ and a larger percentage of these cells degranulate compared to their licensed
Ly49H+ counterparts 73.
Lastly, the tuning hypothesis or rheostat model suggests that NK cells balance
input from signals downstream of inhibitory and activating stimuli to drive a graduated
response. Rejecting the licensing hypothesis, it has been shown that NK cells with no
inhibitory receptors are still responsive to activation stimuli. Research also shows that
NK cells expressing zero, one, two, and three inhibitory receptors show a gradual
increase in responsiveness to stimulation the more receptors are expressed

74-76

. In

further support of the tuning hypothesis, NK cells from mice deficient in MHC-I, deficient
in structural components of the MHC-I protein, or are deficient for ITSM-binding
phosphatases are hypo-responsive77-81. These NK cells are unable to signal through
inhibitory receptors, and therefore, this phenomenon rejects the licensing hypothesis.
Instead it favors the tuning hypothesis, which is quickly becoming more popular in the
NK cell field as more is learned about activation signaling and inhibitory receptor
development.

Use of NK Cells for Therapeutic Purposes
It is a very exciting time to be studying NK cell signaling, as clinicians are
beginning to appreciate NK cells as a cellular immunotherapeutic option. In the last
twenty years, the idea of harnessing and manipulating NK cells for therapeutic purposes
(specifically in the fight against cancer) has stimulated attention.

Researchers like

myself predict NK cell immunotherapy to be the next frontier for cancer research. NK
cells are a unique choice of cells to use for cancer-based immunotherapies because of
19

their ability to kill in an unprimed and non-MHC restricted state. NK cells directly kill
tumor cells or kill via indirect effects, such as cytokine-priming CD8+ T cells or presenting
antigen to dendritic cells. Tumors not only develop mechanisms to avoid T cell
recognition (down regulation of MHC-I) but can even escape NK cell recognition as well.
The loss of adhesion molecules, co-stimulatory molecules, the up-regulation of MHC-I,
and the expression of immunosuppressive cytokines all decrease NK cell effectiveness.
This could be a caveat, but because NK cells have the ability to kill almost on demand,
their use therapeutically can be manipulated in various ways for patient benefit.
Currently, three major approaches are being tested for clinical purposes. They include
1) the use of cytokine-expanded/cytokine-activated autologous NK cells, 2) the adoptive
transfer of KIR-mismatched allogeneic NK cells, and 3) the genetic manipulation of
donor NK cells for improved NK cell function 82.
Early studies have focused on attempts to enhance autologous NK cell function
through increased NK cell killing and NK cell proliferation. This was achieved through
the systemic administration of NK cell activating cytokines, such as IL-2, IL-15, IL-12, IL21, IL-18, and type I interferons

82-86

. IL-15 and IL-2 were first picks for NK cell cytokine

expansion, as these are required for survival and activation respectively. These
cytokine-activated lymphokine activated killer cells (LAKs) have enhanced cytotoxicity
and increased cytokine production against target cell lines in vitro, but this has generally
failed to limit tumor growth in cancer patients.

Additionally, IL-2 administration to

patients caused severe toxicity and induced vascular leak syndrome, dampening this
direct method of treatment. IL-2 expanded LAKs were more effective against cancer
when expanded ex vivo and adoptively transferred or when stimulated with other
cytokines. Of course, toxicity problems and cytokine-induced NK cell apoptosis remain a
20

concern with systemic cytokine administration for autologous expansion and activation
82

.
Allogeneic NK cell transplantation with KIR-mismatch has shown promise as an

effective therapy for AML.

While KIR-mismatched NK cells offer major benefits to

patients by killing target cancer cells of mismatched MHC-I, these cells are allogeneic
and will eventually be rejected by the host immune system

87,88,89

. Ideally, autologous NK

cells with manipulated KIR repertoire (to support KIR-mismatch) would be feasible for
long-term survival and extended killing potential. Ideas on the feasibility of this will be
elaborated on in Chapter IV. Not only are primary cells being used, but also interest has
pushed researchers towards allogeneic NK cell lines to execute tumor cell killing. For
example, the NK-92 cell line is the first and only cell line to be entered in a clinical trial
for NK cell tumor immunotherapy 90,91.
Lastly, genetic manipulation of NK cells for therapeutic purposes is less
established, but creating headway in therapeutic options. NK-92 cells need IL-2 to
survive and divide, but IL-2 has proved to be problematic for many reasons listed
previously. To circumvent some problems, some researchers transduced NK-92 cells
with the IL-2 gene to encourage survival in the absence of exogenously delivered
cytokine

92,93

. Cells were able to survive and thrive for over 5 months without exogenous

cytokine. This has also been shown in primary NK cells with mb-IL-15

94

. Not only can

cell lines be genetically manipulated, but primary NK cells may also be used as a vehicle
for retroviral or lentiviral constructs. This leads us to the potential use of NK cell chimeric
antigen receptors (CARs). Chimeric antigen receptors are single chain antibody variable
fragments targeted against a certain antigen. This is linked to an intracellular signaling
domain, which can contain different signaling motifs—the most tested being CD3ζ
21

chains that contain ITAMs. CAR-expressing T cells have been quite successful in clinical
trials for the treatment of hematological malignancies, specifically against B cell
lymphomas and leukemias. Many more malignancies expressing different target cancer
antigens are being currently tested, but little is known about NK cell CARs. Based on
pre-clinical studies of CAR-NK cells, it is predicted that they could provide targeted killing
and avoid major complications of current CAR-T cell therapy

95

. This will be elaborated

on in the discussion section of the dissertation.

Structure of the Thesis
While NK cell biology has been of interest in recent years due to the similar role NK cells
play to CD8+ effector T cells in cancer and viral immunity, fundamental gaps in our
understanding about how NK cells develop, become educated, and function still remain.
Signaling downstream of activating receptors is critical for NK cell effector functions, like
degranulation and inflammatory cytokine production. Furthermore, it has been shown
that disruption of proteins proximal to activating receptors on an NK cell’s surface results
in skewed NK cell development, specifically in regards to inhibitory receptor repertoire
52,96

. While NK cell biologists tend to separate the concepts of NK cell development,

education, and activation, these processes can all be impacted by signals received
through activating receptors.

Therefore NK cell activation drives development,

education and functional effector-like consequences, but what type of signals contributes
to each of these processes is still unclear.

This thesis aims to address the major

question: What activating signals and/or signaling proteins impact NK cell development,
education and function? Work presented in this thesis will clarify the role of NK cell
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activation in shaping the NK cell inhibitory receptor repertoire during early NK cell
development, which is critical for NK cell education and function. Additionally, this thesis
shows that not all signaling pathways downstream of activating receptors are required
for NK cell effector functions; there are detailed nuances in the signaling pathways that
lead to different effector outcomes.
Inhibitory receptor signaling blunts NK cell activation. There is also data to
suggest that expression of an inhibitory receptor that binds self-MHC-I enhances the
functional capability of an NK cell (licensing).

It is clear from the literature that the

expression of inhibitory receptors might be important for developing NK cell education.
The acquisition of self-binding MHC I inhibitory receptors may help developing NK cells
mature, learn their signaling threshold, and function properly in the periphery (outside of
the bone marrow). In fact, expression of Ly49/KIR receptors, major classes of inhibitory
receptors in mice and humans, is critical for function of NK cells and recognition of target
cells.

NK cells express a diversified repertoire of these receptors, but how does a

developing NK cell know how many or what types of receptors to express in order to
functional in the periphery? In Chapter II, I show that NK cells receive activating signals
during development, which are important for the transcription of Ly49 receptors on
mouse NK cells and KIRs on human NKs. Activation through SLP-76 is critical for this
process, because SLP-76 dependent signaling actively determines the direction of
transcription of a bi-directional promoter of Ly49 receptor genes in immature NK cells.
This suggests that during early development in the bone marrow, NK cells are activated
through activating receptors and induce transcription of Ly49 or KIR genes, which allows
for expression of these inhibitory receptors on an NK cell’s surface, thus aiding in the
creation of diverse, mature NK cells.
23

Activation through SLP-76 not only impacts early NK cell development, but it
leads to two major signaling pathways downstream: DAG and IP3.. Research generated
by another member of my lab elegantly demonstrated an important role for DAG signals,
through ERK activation, in NK cell degranulation, cytotoxic killing, and IFNγ production
65

. These studies were never completely isolated from the other arm of the SLP-76

signaling bi-furcation-- IP3 mediated signaling--which results in sustained Ca2+ entry. The
NK cell literature on roles for sustained Ca2+ signaling in NK cell function is also lacking.
NK cell studies have been performed in human patients with STIM1 or ORAI1 mutations,
which abolish sustained Ca2+ entry

97,98

. These patients have problems with NK cell

degranulation, target cell killing, and cytokine production but the mechanism behind this
finding has yet to be revealed. The principal question I aimed to answer in Chapter III is:
how does sustained Ca2+ signaling impact NK cell function? In Chapter III, I aim to
address this question by using in vitro and genetic models of blocking sustained
Ca2+entry in NK cells and assessing their functional outcome. At odds with the data
published on human patients, I show that murine NK cells are able to retain
degranulation and cell-mediated killing functions in the absence of sustained Ca2+ entry.
These effector functions might be carried out via DAG-mediated signals, perhaps
through PKC activation, in the absence of sustained Ca2+ entry. The production of the
inflammatory cytokine IFNγ was significantly reduced in the absence of sustained Ca2+
entry, and this was found to be due to loss of NFAT activation.
In the final chapter, Chapter IV, I discuss how my findings add to and impact NK
cell biology. I propose ideas for future experiments to answer any remaining and new
biological questions that my research has generated. These emerging questions will
require more experimental effort to fully understand how activation-signaling influences
24

NK cell development and function. This work will be critical for the utilization of NK cells
in clinical scenarios (e.g.adoptive NK cell therapies) and other types of NK cell-specific
immunotherapy and drug targeting.
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CHAPTER II: Activating receptor signals drive receptor diversity
in developing natural killer cells
Work in this chapter has been published in PLOS Biology:
Freund, J., R. M. May, E. Yang, H. Li, M. McCullen, B. Zhang, T. Lenvik, F. Cichocki, S.
K. Anderson, and T. Kambayashi. 2016. Activating Receptor Signals Drive Receptor
Diversity in Developing Natural Killer Cells. PLoS Biol. 14: e1002526.

Introduction
Natural killer (NK) cells are innate lymphocytes that play an important role in
defense against viral infections and tumor clearance. NK cells express a wide variety of
inhibitory and activating receptors, whose downstream signals integrate to dictate a
functional response. For example, the Ly49 family of receptors on murine NK cells plays
a key role in NK cell function. Inhibitory Ly49 receptors (e.g. Ly49A, Ly49G, Ly49C, and
Ly49I) recognize major histocompatibility complex class I (MHC-I) and allow NK cells to
carry out “missing-self” recognition, a process that eliminates cells with abnormally
down-regulated MHC-I expression due to certain types of infection or neoplastic
transformation

8,99

. Also, the activating receptor Ly49H binds to cytomegalovirus (CMV)-

encoded m157 protein, aiding in the clearance of CMV-infected cells. Ly49 receptors are
acquired in a sequential and variegated manner during development, which yields a
diverse repertoire of NK cells with various Ly49 receptor expression patterns. Since
each Ly49 receptor recognizes a subset of MHC-I alleles, the Ly49 receptor expression
pattern on an individual NK cell determines its target cell specificity. Thus, unlike T and B
cells that create antigen-specific diversity by genetic recombination, NK cells generate
ligand-specific diversity by acquiring an assortment of inhibitory and activating receptors;
however, the mechanisms that regulate NK cell receptor acquisition during development
26

are not well understood.
NK cells commence their acquisition of Ly49 receptors during the immature NK
(CD3ε-CD122+NK1.1+DX5-) bone marrow (BM) stage

6,17

. Ly49 receptor genes are

activated in a specific order, and each receptor possesses a developmental timeframe
for the initiation of expression, which is maintained for the lifetime of the NK cell.
However, once this window of opportunity passes, the NK cell can never express that
Ly49 receptor

100

. Ly49 receptor expression patterns are influenced by polymorphisms in

the Ly49 locus and the MHC haplotype expressed in each strain of mouse. Thus, the
fraction of NK cells expressing a particular Ly49 receptor is similar within a given mouse
strain. For example, ~10% and ~50% of NK cells in C57BL/6 mice express Ly49A and
Ly49G2, respectively.
Ly49 receptor gene transcription is controlled by at least two distinct promoters:
Pro1, which is active in immature NK cells, and Pro2, which is critical in maintaining
expression in mature NK cells

43,45,46,101

. Each Ly49 receptor possesses a unique Pro1

promoter that acts as a bi-directional switch. Transcription factors bind to Pro1 on either
the positive (forward) or negative (reverse) strand in a probabilistic manner, thus
determining forward or reverse transcription from this promoter. Transcription of Pro1 in
the forward direction leads to activation of Pro2 43,45. Pro2 can be regulated through DNA
methylation, and forward transcription of Pro1 is thought to remove a repressor complex,
allowing for acetylation of histones and/or demethylation of DNA at the Pro2 promoter
46,102

. This promotes Ly49 transcription in mature NK cells and the stable expression of

the receptor. Pro1-mediated transcription in the reverse direction results in no Pro2
activity and therefore no Ly49 receptor expression. Thus, the proportion of NK cells

27

expressing a given Ly49 receptor is determined by the probability of the specific Pro1
promoter to transcribe in the forward vs. reverse direction.
Two important factors that shape the NK cell inhibitory Ly49 receptor profile are
the MHC haplotype and the MHC-binding specificities of the inhibitory receptors
themselves

103

. However, the mechanism by which inhibitory receptor specificity and

MHC haplotype regulate NK cell receptor acquisition is unclear, especially since
inhibitory receptors block (through recruitment of phosphatases such as SHP-1 and
SHIP) rather than transmit signals to the NK cell. Mice with NK cells lacking SHP-1 or
SHIP display increased proportions of Ly49 receptor-expressing NK cells

80,81,104,105

,

suggesting that inhibitory receptor-induced phosphatase activity attenuates Ly49
receptor acquisition. To explain how this might work, we hypothesized that activating
receptor signals are the driving force behind inhibitory receptor acquisition. We propose
that MHC-I influences the acquisition of inhibitory receptors by blocking this activating
signal, which impedes expression of additional inhibitory receptors. This notion is difficult
to test by deleting specific activating receptors, as NK cells express numerous activating
receptors that utilize various signaling modules. Instead, we took advantage of mice
lacking the adaptor molecule SH2 domain-containing leukocyte protein-76 (SLP-76).
Although initially described as being dispensable for NK cell activation in IL-2-expanded
splenocyte cultures

27,59

, subsequent studies have shown that SLP-76 is indeed critical

for signal transduction downstream of multiple NK cell activating receptors

27,29,60

. In this

study, we report that activating signals downstream of SLP-76 drive the stable
expression of a subset of Ly49 receptors by increasing the probability of forward Ly49
transcription from the bidirectional Pro1 promoter. Our data support a model where
competing activating and inhibitory receptor signals determine the probability of Ly49
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receptor expression, which ultimately shapes an appropriate inhibitory receptor
repertoire during NK cell development.

Results
SLP-76-derived signals are required for optimal induction of Ly49 receptor and
KIR expression by developing NK cells.
To test whether NK cell effector function following activation is dependent on
SLP-76, wild-type (WT) and SLP-76 knockout (KO) NK cells were stimulated through
three distinct activating receptor families (ITAM-dependent: NK1.1, Ly49H; costimulatory-like: NKG2D; SAP-dependent: 2B4). We found that the baseline expression
level (MFI) of all activating receptors on SLP-76 KO NK cells was comparable to controls
(Fig. 2.1A). Upon stimulation with antibodies against the various activating receptors,
SLP-76 KO NK cells were significantly defective in degranulation (as measured by
surface CD107a) compared to WT NK cells (Fig. 2.1B-C).
Given that SLP-76-mediated signals were critical for NK cell function downstream
of multiple activating receptors, we next determined if SLP-76-mediated signals
impacted NK cell development. The percentage and absolute number of splenic NK cells
in SLP-76 KO mice were higher than WT littermate controls (Fig. 2.1D-E). This increase
in NK cells was most likely a consequence of the increased availability of homeostatic
cytokines due to the lack of competing T cells in SLP-76 KO mice. We also examined
expression of SLP-76 in all stages of NK cell development and found that SLP-76 mRNA
was highly expressed in both the early and late stages of NK cell development (Fig.
2.1F). Next, WT and SLP-76 KO NK cells were analyzed for expression of activating and
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inhibitory receptors, including the Ly49 family of receptors. A strikingly significant
decrease in Ly49 receptor-expressing splenic and BM NK cells was observed in SLP-76
KO mice. This included both inhibitory (Ly49A, Ly49G2, Ly49C, Ly49I) and activating
(Ly49D and Ly49H) family members (Fig. 2.1G-H). The earliest acquired receptors,
Ly49A and Ly49G2, were most affected by the loss of SLP-76 (~90% reduction)
compared to Ly49C and Ly49I (~50% reduction). Not all MHC-I binding inhibitory
receptors were reduced, as the proportion of CD94/NKG2A expressing NK cells was
unaltered in SLP-76 KO mice (Fig. 2.1G).
Since Ly49 receptor acquisition can also occur at later stages of NK cell
development, a maturation defect in SLP-76 KO NK cells could be responsible for the
phenotype observed. To test this possibility, we assessed splenic NK cell maturation
using the cell surface markers CD27 and CD11b

18

and found that NK cells were more

developmentally mature in SLP-76 KO mice (increased proportion of CD27-CD11b+ NK
cells (Fig. 2.1I). Moreover, Ly49 receptor expression by SLP-76 KO NK cells was
decreased at every stage of splenic maturation compared to WT controls (Fig 2.2).
These data show that an NK cell maturation defect was not responsible for the reduction
in Ly49 receptor expression.
Killer immunoglobulin-like (KIR) receptors on human NK cells are functional
orthologs of Ly49 receptors in mice. To test whether SLP-76-derived signals also
contributed to KIR acquisition, we differentiated human NK cells from CD34+ umbilical
cord blood cells transduced with SLP-76 or scrambled shRNA in vitro for 21 days. SLP76 shRNA transduction resulted in a decrease in SLP-76 expression, which correlated
with a reduced ability to activate KIR gene expression (KIR cocktail of KIR2DL1,
KIR2DL2/DL3, KIR3DL1) but not CD56 or NKp46 (Fig. 2.3). These data along with the
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Ly49 receptor acquisition defect in SLP-76 KO NK cells suggest that NK cells rely on
SLP-76-dependent activation signals for a MHC-I binding inhibitory receptor acquisition.

The loss of Ly49 receptor expression in SLP-76 KO NK cells is MHC-I haplotypeindependent.
To obtain a more global picture of the Ly49 receptor repertoire of SLP-76 KO NK
cells, we examined the co-expression pattern of inhibitory Ly49 receptors. This analysis
revealed that SLP-76 KO mice have an expanded population of Ly49 receptor-negative
NK cells. Although the proportion of NK cells that express Ly49C or Ly49I was reduced
in SLP-76 KO mice (Fig 2.1G), there was relative preservation of Ly49C and Ly49I
single-positive NK cells that did not co-express other Ly49 inhibitory receptors (Fig.
2.4A). Ly49C and Ly49I bind to MHC-I (H2-Kb) in C57BL/6 mice, as opposed to Ly49A
and Ly49G2 that bind H-2Dd and do not possess ligands in C57BL/6 mice. Since MHC-I
interactions with Ly49 receptors shape the Ly49 repertoire

74,104-106

, we wondered

whether the relative preservation of Ly49C and Ly49I expression could be related to
their ability to bind MHC-I in C57BL/6 mice. To test this, we bred SLP-76 KO mice to the
B10.D2 mouse strain. If ligand binding were responsible for the preservation of Ly49
receptor expression, the proportion of Ly49A+ and Ly49G2+ NK cells would be relatively
preserved in SLP-76 KO.B10.D2 mice, as B10.D2 mice express H-2Dd. However, we
found that SLP-76 KO-B10.D2 NK cells also displayed a similarly defective Ly49
receptor repertoire as compared to SLP-76 KO NK cells on a H-2b background (Fig.
2.4B-C). These data suggest that the Ly49 receptor repertoire defect in SLP-76 KO NK
cells is independent of MHC-I haplotype.
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SLP-76-derived signals regulate some, but not all, Ly49 receptors in an NK cellintrinsic manner.
As SLP-76 is expressed in almost all hematopoietic cells, SLP-76 KO mice
harbor defects in multiple hematopoietic lineages

107

. Although we predicted that SLP-

76-derived signals controlled Ly49 receptor acquisition in an NK cell-intrinsic manner, it
was still possible that the defects arose secondary to cell-extrinsic effects. To address
this, we generated mixed BM chimeric mice using BM from congenically disparate WT
and SLP-76 KO mice mixed at a 2:1 ratio. Ten to twelve weeks after reconstitution,
although some variability was seen, the contribution of SLP-76 KO bone marrow to nonT cell/non-NK cells compared to NK cells was similar, suggesting that there was no
significant advantage or disadvantage of SLP-76 deficiency in NK cell development (Fig.
2.5A). Consistent with our hypothesis, we found that the proportion of NK cells
expressing Ly49A, Ly49G2, and Ly49I was decreased in SLP-76 KO BM compared to
WT BM-derived NK cells (Fig. 2.5B). However, no differences in the proportion of Ly49C,
Ly49D, and Ly49H expressing NK cells was observed between SLP-76 KO BM and WT
BM-derived NK cells (Fig. 2.5C). Thus, although a subset of Ly49 receptors (Ly49A, G2,
and I) was regulated in an NK cell-intrinsic manner, Ly49C, Ly49D, and Ly49H were
controlled by a SLP-76-dependent, NK cell-extrinsic mechanism.
It has been published that mice deficient in MHC-I or inhibitory receptor signaling
harbor increased proportions of Ly49-expressing NK cells

80,81,104,105

. We hypothesized

that the proportion of Ly49 receptor-expressing NK cells is increased in such mice
because activation signals are unopposed by MHC-binding inhibitory receptors during
NK cell development. The NK cell-intrinsic regulation of some but not all Ly49 receptors
provided us with an opportunity to test this hypothesis, as we would predict that only NK
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cells expressing Ly49 receptors regulated by an NK cell-intrinsic mechanism would be
increased in MHC-I-deficient mice. We examined the Ly49 receptor repertoire of MHC-Ideficient β2m KO mice and observed an increase in the proportion of NK cells
expressing Ly49 receptors that are regulated in a cell-intrinsic manner (Ly49A, Ly49G2,
and Ly49I). In contrast, the proportion of NK cells expressing Ly49 receptors regulated in
an NK cell-extrinsic manner (Ly49C, Ly49D, and Ly49H) were the same or reduced in
β2m KO mice (Fig. 2.5D). These findings suggest that the lack of inhibitory ligands
(MHC-I), presumably leading to more NK cell activation, results in an increased chance
of NK cells expressing cell-intrinsic Ly49 receptors.

Distinct signaling pathways upstream of SLP-76 differentially contribute to Ly49
receptor acquisition by NK cells.
In NK cells, SLP-76 can be recruited to the membrane by two independent
proximal signaling complexes: one involving LAT family members (LAT1/LAT2) and the
other involving ADAP

27,108

. As both SLP-76 signaling complexes are important for NK

cell function downstream of activating receptors, we predicted that both LAT1/LAT2 and
ADAP proteins would contribute to Ly49 receptor acquisition by NK cells. Surprisingly,
we found that these SLP-76 signaling complexes differentially contributed to Ly49
receptor acquisition. A significantly decreased proportion of NK cells expressing Ly49A
and Ly49I was observed in LAT1/LAT2 DKO but not in ADAP KO mice. Conversely, a
significantly smaller proportion of NK cells expressing Ly49G2 was observed in ADAP
KO but not LAT1/LAT2 DKO mice (Fig. 2.6A). The LAT1/LAT2/ADAP TKO mice
displayed decreased proportions of all three Ly49 receptors similar to the SLP-76 KO NK
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cells. The upstream ADAP and LAT pathways also differently affected NK cell-extrinsic
Ly49 receptors.

Ly49C was primarily driven by LAT1/LAT2-dependent signals while

Ly49D and Ly49H utilized both pathways for their expression (Fig. 2.6B). These data
point to a differential influence of SLP-76 upstream signaling pathways on Ly49 receptor
induction during NK cell development.

SLP-76 regulates the probabilistic switch function of the Ly49G Pro1 promoter.
To test whether the reduced frequency of Ly49 receptor-expressing NK cells was due to
decreased transcription, we quantified mRNA transcripts of an NK cell-intrinsic Ly49
receptor at early and late stages of NK cell development in WT and SLP-76 KO mice.
We found that Ly49G2 mRNA transcripts were reduced in SLP-76 KO immature (iNK)
and mature (mNK) BM subsets compared to WT controls (Fig. 2.7A). Ly49G was chosen
as a model gene since this receptor is expressed on half of NK cells.
Ly49 receptor gene transcription is driven off the Pro1 promoter region in
immature NK cells and the Pro2 region during maturity

43,45,46,101

. Transcription factors

can bind to Pro1 on either the positive (forward) or negative strand (reverse) in a
probabilistic manner, and this determines the directionality of transcription from this
promoter. Forward transcription allows for stable expression of that Ly49 receptor in
mature NK cells while reverse transcription leads to no Ly49 expression. To test whether
SLP-76-mediated signaling affected transcription from the Pro1 promoter, forward and
reverse transcripts from the Ly49G Pro1 promoter were examined. As expected,
compared to WT NK cells, DX5− (BM iNK cells) and DX5+ (BM mNK cells) SLP-76 KO
NK cells expressed significantly reduced levels of Ly49G Pro1 forward transcripts (Fig.
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2.7B). However, we also surprisingly observed that SLP-76 KO NK cells expressed
increased Ly49G Pro1 reverse transcripts in iNK and mNK BM subsets compared to WT
NK cells (Fig. 2.7B). These data suggest that SLP-76-mediated signaling affects Ly49
receptor acquisition in developing NK cells by promoting Pro1 forward over reverse
transcription, thereby increasing the probability of NK cells to express a given Ly49
receptor.
We further investigated the accessibility of chromatin at Ly49G Pro1 and Pro2 in
WT and SLP-76 KO NK cells, by performing a chromatin immunoprecipitation for histone
3 lysine 9 acetylation (H3K9Ac), an indicative marker for open/accessible chromatin. The
Pro2 loci of Ly49G is CpG poor, and has been previously shown to be epigenetically
regulated by H3K9Ac

109

. Based on the reduction in Ly49G2 expression in SLP-76 KO

NK cells, we predicted there to be less H3K9Ac, and less Pro2-mediated transcription.
H3K9Ac was observed at Pro2 of Ly49g but not at Ly49e (silenced in adult NK cells) in
WT NK cells. Surprisingly, however, Ly49G Pro2 H3K9Ac was similar between WT and
SLP-76 KO NK cells (Fig. 2.7C), perhaps suggesting that Pro2 chromatin accessibility is
not sufficient to drive Ly49G expression in mature NK cells. Although the role of H3K9Ac
at Pro1 is unknown, we found SLP-76 KO NK cells showed significantly decreased
Ly49G Pro1 H3K9Ac compared to WT controls (Fig 2.7C). These data suggest that SLP76-derived signals mainly control transcriptional activity at the Pro1 promoter and that
epigenetic alterations at the Ly49 Pro1 loci may control receptor expression in mature
splenic NK cells.
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Discussion
Although NK cells are part of the innate immune system, NK cells exhibit many features
of adaptive immune cells. Unlike T cells and B cells that create antigen specificity by
genetic recombination, NK cells create diversity by expressing a seemingly “random”
assortment of inhibitory and activating receptors The various combinations of expressed
receptors generate ligand-specificity, allowing subsets of NK cells to respond, expand,
and differentiate into memory-like cells in a ligand-specific manner, as well as create a
diverse repertoire within the NK cell pool

110,111

. However, how NK cells determine which

inhibitory receptors to express on their cell surface, during a narrow window of
development, was largely unknown. The data presented in this manuscript support a
model by which NK cell activation during development drives inhibitory receptor
acquisition on immature NK cells. Our model proposes that during early NK cell
development, NK cells are activated via interactions between activating receptors and
their ligands expressed by BM stroma. Activation of NK cells results in a signaling
cascade that promotes the transcription of different Ly49/KIR genes. The NK cell
acquires these receptors until a self-binding inhibitory receptor is expressed on the cell
surface and blocks the activating signal (Fig. 2.8).
Our model potentially explains how MHC-I interactions with NK cell inhibitory
receptors shape the inhibitory receptor repertoire. The regulation of Ly49/KIR induction
by activating receptor-derived signals provides a mechanism whereby developing NK
cells can generate a ligand-specific receptor repertoire that appropriately recognizes
missing self. Furthermore, the expression of a self-binding inhibitory receptor increases
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the functional capacity of NK cells, a process known as licensing. Thus, our model
suggests that strong activating signals during NK cell development increase the
likelihood of developing more functionally active licensed NK cells that can carry out
missing self-recognition.
SLP-76 KO mice harbored an increased fraction of the most mature subset of NK
cells. However, the decreased proportion of Ly49 receptor-expressing NK cells in SLP76 KO mice could not be explained by differences in maturation, since the proportion of
NK cells expressing Ly49 receptors was significantly reduced at each stage of NK cell
maturation in SLP-76 KO mice. Our analysis showed that the fraction of Ly49 receptorexpressing NK cells was similar among all maturation stages except for Ly49I, which
was overrepresented in the most mature NK cell subset in WT mice. Interestingly, the
proportion of Ly49I-expressing NK cells was relatively preserved compared to Ly49A or
Ly49G2-expressing NK cells. This could be potentially explained by the increased
maturation status of SLP-76 KO NK cells, since almost all Ly49I-positive NK cells in
SLP-76 KO mice resided in the most mature NK cell subset. Alternatively, self-binding
Ly49 receptors such as Ly49I might drive NK cell maturation, yielding more mature NK
cells in SLP-76 KO mice. Further investigation is required to understand how SLP-76derived signals and self-MHC-I binding Ly49 receptors impact NK cell maturation.
We were surprised to find that not all Ly49 receptor acquisition was intrinsically
driven by SLP-76 signals in NK cells. While Ly49A, Ly49G2, and Ly49I were acquired in
a SLP-76-dependent NK-cell intrinsic manner, Ly49C, Ly49D, and Ly49H were regulated
in an NK cell-extrinsic manner. This suggests another cell type is necessary to generate
a full Ly49 receptor repertoire. It is possible that myeloid lineage cells such as dendritic
cells (DCs) may be responsible for NK cell activation that leads to Ly49 receptor
37

expression

112

. NK cells and DCs form stimulatory synapses, resulting in IL-12 secretion

and IL-15 trans-presentation. IL-12 is critical for optimal NK cell activation by DCs, and
IL-15 is required for NK cell survival and Ly49 receptor expression
critical for murine DC migration and cell-cell contact

114

113

. Since SLP-76 is

, the interaction of DCs with NK

cells may be important for cell-extrinsic Ly49 receptor expression.
We previously reported that LAT1/LAT2 and ADAP can independently recruit
SLP-76 to NK cell activation synapses

27

. As both signaling pathways are required for

optimal NK cell activation, we predicted that they would equally contribute to Ly49
receptor acquisition by developing NK cells. However, LAT1/LAT2 was more important
for Ly49A and Ly49I, whereas ADAP contributed to Ly49G2 expression. LAT1/LAT2
signaling pathways primarily contributed to the extrinsically regulated Ly49C and partially
impacted Ly49D and Ly49H. ADAP only contributed to Ly49D and Ly49H. The Ly49
receptor phenotype of ADAP KO NK cells is supported from recently published data on
SLP-76ace/ace mice that contain a mutation in the SH2 domain of SLP-76, where ADAP
binds

115

. Perhaps, activating receptors that preferentially use either ADAP or

LAT1/LAT2 to recruit SLP-76 are engaged at different times during NK cell development,
leading to the expression of Ly49 receptors in a specific order. Alternatively, each Ly49
receptor Pro1 promoter may be differentially affected by the assortment of transcription
factors induced by the ADAP or LAT1/LAT2 signaling pathways.
Alteration of the probabilistic switch function of the Ly49 Pro1 promoter provides
a mechanism that explains how SLP-76 signaling could increase Ly49 receptor
acquisition. Ly49 receptor expression has been shown to occur in a stochastic manner
21,40

, and the probabilistic mechanism has been explained by differential binding of

transcription factors to either forward or reverse promoter elements in the Pro1 bi38

directional promoter. Transcription factors, such as NFκB, bind this region and are
inducible following activating receptor signaling. One study has explored the role of
NFκB in NK cell development and Ly49 receptor expression, but the results showed only
a small decrease in the proportion of Ly49 receptor-expressing NK cells

116

. Other

transcription factors, such as AML and Ets-1, are expressed in NK cell progenitors prior
to Ly49 receptor transcriptional initiation, but it is possible that activation induced signals
and other transcription factors contribute to the stabilization of the transcriptional
landscape. For example, Ca2+-dependent NFAT and CREB binding sites in the Pro1
region of Ly49G2 may contribute to forward transcription. Studies examining the
contribution of Ca2+ signaling to Ly49 receptor acquisition by NK cells are currently
ongoing.
Since Pro1 forward transcription is thought to control the accessibility of Pro2 in
mature NK cells, we predicted that SLP-76 KO NK cells would exhibit decreased Pro2
chromatin accessibility as measured by H3K9Ac at Ly49G Pro2. However, we found that
SLP-76 KO and WT NK cells exhibited equivalent H3K9Ac at Pro2, despite decreased
Ly49G transcripts in SLP-76 KO NK cells. Instead, we found that H3K9Ac at Pro1 was
almost absent in SLP-76 KO NK cells, suggesting that SLP-76-derived signals impacted
Pro1 accessibility. This suggests that Pro1 accessibility might be important for Ly49
receptor transcription in mature NK cells and that Pro2 accessibility alone is insufficient
to drive Ly49 transcription. This is in line with a recent report proposing that in addition to
being a bidirectional switch, Pro1 may act as an enhancer for Ly49 receptor expression
in mature NK cells

117

. Further studies will be required to elucidate the exact role of Pro1

H3K9Ac in control of Ly49 receptor expression.
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SLP-76-silenced human NK cells differentiated in culture were defective in
human killer-cell immunoglobulin-like receptor (KIR) acquisition. Although the in vitro
differentiation system may not precisely recapitulate human NK cell development in vivo,
these data suggest that KIR acquisition might be influenced by SLP-76-dependent
signals. It has recently been shown that KIR expression may be transcriptionally
regulated in a manner similar to Ly49 receptors. There are promoter regions in KIRs
similar to the Pro1 and Pro2 elements of Ly49 genes; however, their relative location is
inverted. A unidirectional promoter/enhancer is located upstream, and a proximal Pro1like region near the transcriptional start site is methylated in non-expressed KIRs

118,119

.

The bi-directional proximal promoter has putative binding sites for transcription factors
such as Sp1 and YY1

120

. It is thought that the antisense transcripts generated from the

proximal switch produce a small RNA that is involved in the transcriptional silencing of
KIRs through methylation of the proximal promoter region

121,122

. The presence of a bi-

directional switch in human KIRs and murine Ly49s suggests a conserved regulatory
mechanism of inhibitory receptor acquisition by NK cells. Thus, our studies on activation
signals driving Ly49 and KIR expression may also shed light on mechanisms by which
KIRs are acquired on human NK cells.
Further investigation is needed to determine the exact transcription factors
required for inhibitory receptor acquisition, as differences in the proximal signaling
pathways suggest differential regulation of the Ly49 receptors. Nevertheless, our work
highlights the complexity of Ly49 regulation. The results from this study are likely to be
applicable to the regulation of human KIR receptors123-125. Our data support a model
where competing activating and inhibitory receptor signals determine the probability of
inhibitory receptor expression, which ultimately shapes the inhibitory receptor repertoire
40

during NK cell development and creates appropriate ligand-specific diversity within the
NK cell pool.
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Figure 2.1 SLP-76 is important for Ly49 receptor expression and activation downstream of
multiple NK cell activating receptors. (A) Representative histograms of NK cell (gated on
+
+
NKp46 DX5 splenocytes) expression of multiple activating receptors are shown (WT: tint; SLP76 KO: black line). (B) Representative histograms of CD107a expression by WT and SLP-76 KO
NK cells post stimulation from 4 independent experiments are shown. (C) %CD107a expressing
NK cells are represented as mean ± SEM of 4 independent experiments (n=6 mice). Ly49H+
stimulated NK cells are gated on Ly49H cells. (D) The percent and (E) total number of splenic
+
+
−
NK cells (NK1.1 NKp46 CD3ε ) were calculated and represented as mean percent positive ±
SEM of n = 4-5 mice/group. (F) qPCR was performed for SLP-76 (lcp2) and GAPDH
−
+
−
(housekeeping gene) with RNA from sorted BM NK cells [CD3ε CD122 NK1.1 (pNK), CD3ε
−
+
+
−
−
+
+
−
+
+
CD122 NK1.1 DX5 (iNK), CD3ε NK1.1 DX5 (mNK)], splenic CD3ε NK1.1 DX5 (mNK) and
+
splenic T cells (CD3ε ). Data are from 3 experimental replicates and is graphed as % of control
(splenic mNK). *p<0.05, **p<0.01, and ***p<0.001 by paired student’s t test. (G) Splenic and (H)
BM NK cells from WT (black bars) and SLP-76 KO (white bars) mice were assessed for
expression of Ly49 inhibitory receptors (Ly49A, Ly49G2, Ly49C, Ly49I), Ly49 activating receptors
(Ly49D and Ly49H), and NKG2A/C/E. The proportion of receptor-expressing NK cells from
multiple mice is represented as mean percent positive ± SEM of n = 4-5 mice/group. (I) CD27 and
CD11b expression by WT (black) and SLP-76 KO (white) NK cells is represented as percent
positive ± SEM of n=5-6 mice. *p<0.05, **p<0.01, ***p<0.001, and ns = not significant by
student’s t test.
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Figure 2.2. Ly49 receptor expression is reduced at all stages of NK cell splenic maturation.
Ly49 receptor expression is reduced at all stages of NK cell splenic maturation. Ly49 receptor
expression was assessed at three stages of splenic NK cell maturation in WT (black bars) and
+
−
SLP-76 KO (white bars) mice. Maturity in the spleen evolves as follows: CD27 CD11b (least
+
+
−
+
mature), CD27 CD11b , CD27 CD11b (most mature). Data is represented as percent positive ±
SEM of three independent experiments (n = 3 mice). *p < 0.05, **p < 0.01, ***p < 0.001, and ns =
not significant by unpaired student’s t test.
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Figure 2.3. Human NK cells require SLP-76 for optimal KIR acquisition during
development. (A) Knockdown of SLP-76 from differentiated human NK cells transduced with
scramble (black bars) or SLP-76 shRNA (white bars) at Day 21 culture is shown. SLP-76 MFI
was calculated from scramble or SLP-76 shRNA transduced donors. Data is plotted as MFI ±
SEM of two independent experiments (n=5 donors over two experiments). *p < 0.05, ***p <
+
0.001, by paired student’ s t test. (B) Representative flow plots and histograms of CD56 CD3
+
+
NKp46 and KIR (KIR2DL1, KIR2DL2/DL3, KIR3DL1 antibody cocktail) NK cells are represented
asmean percent positive ± SEM of two independent experiments (n=5 donors over two
experiments). *p < 0.05, ***p < 0.001, by paired student’ s t test. *Experiments performed by
B. Zhang, T. Lenvik, F. Cichocki.
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Figure 2.4. Ly49 receptor expression loss in SLP-76 KO NK cells is independent of MHC-I
haplotype. (A) The co-expression pattern of inhibitory Ly49 receptor in WT vs SLP-76 KO splenic
NK cells was assessed through SPICE analysis. (B) Representative histograms of Ly49 receptor
expression by WT B10.D2 and B10D2.SLP-76 KO splenic NK cells are shown. (C) The proportion
of Ly49 receptor-expressing NK cells from multiple WT B10.D2 (black bars) and B10D2.SLP-76
KO (white bars) mice is represented as mean percent positive ± SEM of (n = 3 mice/group).
*p<0.05, ***p<0.001 by student’s t test.
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Figure 2.5. A subset of Ly49 receptors is regulated in an NK cell-intrinsic SLP-76dependent manner. (A) The percentage of Non-T/NK cells and NK cells from WT competitor
(CD45.2) was assessed in each mixed bone marrow chimeric mouse. One representative
experiment of 4 experiments is plotted (n = 3 mice). ns = not significant by paired student’s t test.
(B) The proportion of Ly49 receptor-expressing NK cells derived from WT or SLP-76 KO BM from
mixed BM chimeras was assessed. One representative experiment of 4 experiments is shown as
mean percent positive ± SEM of n=3 mice. *p<0.05, **p<0.01, ***p<0.001, ns=not significant by
paired student’s t test. (C) Ly49 receptor expression on splenic NK cells from WT (black bars)
and β2m KO (open bars) mice was assessed and represented as mean percent positive ± SEM
of n = 10 mice. *p<0.05, **p<0.01, ***p<0.001, and ns = not significant by student’s t test.
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Figure 2.6. Upstream signaling pathways of SLP-76 differentially contribute to induction of
Ly49 expression by NK cells. (A) Splenic NK cells from WT, ADAP KO, LAT1/LAT2 DKO, and
ADAP/LAT1/LAT2 TKO NK cells were assessed for expression of NK cell-intrinsic Ly49A,
Ly49G2, Ly49I and (B) NK cell-extrinsic Ly49C, Ly49D, and Ly49H. Data are represented as
mean percent positive ± SEM of n=3-4 mice per genotype. *p<0.05, **p<0.01, ***p<0.001, and
ns=not significant by student’s t test.
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Figure 2.7. SLP-76 regulates Ly49 gene transcription during early BM development. (A)
qPCR was performed for Ly49G2 and GAPDH (housekeeping gene) with RNA from sorted BM
−
+
−
NK
cells
at
various
developmental
stages
[CD3ε CD122 NK1.1
(NKp),
−
+
+
−
−
+
+
−
+
+
CD3ε CD122 NK1.1 DX5 (iNK), CD3ε NK1.1 DX5 (mNK)] and splenic CD3ε NK1.1 DX5 (NK).
One representative of 2 independent experiments is shown. (B) qPCR for Ly49G Pro1 forward
+
and reverse transcripts was performed on DX5 (iNK) and DX5 (mNK) BM NK cells from SLP-76
KO and littermate control mice. β-actin was used as a housekeeping gene. One representative of
4 independent experiments is shown. (C) ChIP for histone 3 lysine 9 (H3K9) acetylation was
performed on splenic NK cells from WT and SLP-76 KO mice. The results were normalized as the
percentage of the input (%input) from Ct values, and data are represented as mean % input ±
SEM from 3 independent experiments. *p<0.05, **p<0.01, ***p<0.001, and ns=not significant by
paired student’s t test. *Experiments in collaboration with H. Li, M. McCullen, and S.K.
Anderson.
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Figure 2.8. Activating receptor-mediated signaling is the driving force for Ly49 receptor
induction during NK cell development. Activating receptors on developing NK cells are
stimulated by their respective ligands via interactions with BM stromal cells. This interaction
results in the activation of transcription factors that promote Ly49 receptor expression. If the Ly49
receptor that is acquired does not recognize self-MHC I, the NK cell continues to receive
“positive” activating receptor signals, which increases the probability of the NK cell to acquire
another Ly49 receptor. This process occurs until a self-MHC I binding Ly49 is acquired, which will
dampen the activating receptor signal. This NK cell can then mature and migrate to peripheral
tissues to perform “missing-self” recognition.
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CHAPTER III: Murine natural killer cells degranulate and retain
cytotoxic function without store-operated calcium entry.

Introduction
Intracellular signaling is a biochemical process that allows cells to respond to
extracellular cues. Signaling is controlled by direct modification to proteins (e.g.,
phosphorylation) and by binding of ions such as Ca2+. These modifications influence
protein-protein interactions, which have broad downstream consequences for cells,
including changes in transcription, cell motility, mitochondrial function, and cell death 126.
The mobilization of Ca2+ ions from the extracellular environment into the
cytoplasm

is

important

for

immune

cell

activation

downstream

immunoreceptors or G protein-coupled receptors (GPCR)s

127

of

activating

. Engagement of these

activating receptors leads to the phosphorylation of phospholipase C (PLC), which
hydrolyzes phosphatidylinositol-4,5-bisphosphate (PIP2) into the second messengers
diacylglycerol (DAG) and inositol-1,4,5-triphosphate (IP3)

128,129

. The basal concentration

of intracellular Ca2+ is very low (~100nM) as compared to the extracellular environment,
but this quickly changes when IP3 binds to IP3-receptors on the endoplasmic reticulum
(ER), causing the release of ER Ca2+ stores into the cytoplasm (raises cytoplasmic
concentration to ~1uM). ER depletion dissociates Ca2+ ions from the ER Ca2+-sensors
stromal interacting molecules 1 and 2 (STIM1/2). STIM1/2 oligomerize and activate
ORAI1-3 (Ca2+ release-activated channel; CRAC) on the plasma membrane to facilitate
entry of extracellular Ca2+ into the cytoplasm. This process is important for sustaining of
high levels of Ca2+ in the cytoplasm after immune activation and is referred to as store
operated Ca2+entry (SOCE) 69,128,130.
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Sustained Ca2+ entry mediated through SOCE is critical for T cell specific
functions. STIM1/2-deficient T cells cannot mobilize Ca2+ through the CRAC channel
following TCR stimulation

71

. They have defects in proliferation following TCR

stimulation, fail to produce IL-2 and IFNγ, and have impaired degranulation. Because of
these defects, STIM1/2-deficient T cells have significantly compromised cytotoxicity
against tumors

131

, defective control of acute infections, and possess reduced memory T

cell formation and persistence 132.
Like CD8+ T cells, the key functions of NK cells are to produce inflammatory
cytokines and perform cell-mediated killing. NK cells initiate Ca2+ signaling following
activating receptor stimulation

72

. A few studies have probed the requirement of SOCE in

NK cell effector function by examining rare patients with STIM1 or ORAI1 mutations

97,98

.

These patients had normal frequencies of NK cells, expression of NK cell-defining
markers, LFA-1 activation, and granule polarization.

Similar to their T cells, these

patients exhibited defective NK cell cytokine production and problems with target cell
killing due to degranulation defects.
In this study, we sought to investigate the contribution of the DAG and Ca2+
signaling pathways to NK cell effector function. Surprisingly, we found that activation of
the DAG signaling pathway alone was sufficient to induce degranulation by NK cells.
Moreover, while NK cells displayed defective IFNγ production, they retained the ability to
degranulate and kill target cells in the absence of SOCE. These data suggest that unlike
CD8+ T cells, which need sustained Ca2+ signaling for cytotoxicity, primary murine NK
cells do not require SOCE to perform cell-mediated cytotoxicity.
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Results and Discussion
Activation of the DAG signaling pathway in the absence of extracellular Ca2+ is
sufficient to induce NK cell degranulation
PLCγ transduces its downstream signals through the activation of the DAG and Ca2+
signaling pathways. To individually test the contribution of these two distinct signaling
pathways in NK cell activation, we stimulated primary splenic C57BL/6 (WT) NK cells
with the Ca2+ ionophore, ionomycin (Iono), or the DAG analog, phorbol 12-myristate 13acetate (PMA). As expected, stimulation of NK cells with PMA and Iono induced robust
expression of both IFNγ and cell surface CD107a, a marker for degranulation (Fig. 3.1
A-C). Although a small fraction of NK cells stimulated with Iono alone expressed IFNγ,
Iono alone did not induce any cell surface CD107a expression (Fig. 3.1 A-C). Similarly,
PMA alone negligibly up-regulated IFNγ expression on NK cells. However, we
unexpectedly found that PMA alone robustly induced cell surface CD107a expression by
NK cells (Fig. 3.1 A-C). These data suggest that DAG signaling may be sufficient to
trigger degranulation by primary NK cells.
Although PMA alone would not be expected to elevate cytoplasmic Ca2+ through
the activation of SOCE, we wondered whether extracellular Ca2+ entering the cell from
other membrane channels contributed to the effects of PMA-induced degranulation. To
test this possibility, we stimulated WT splenocytes with PMA in the presence and
absence of extracellular Ca2+. The proportion of NK cells expressing CD107a in Ca2+sufficient media (2mM Ca2+) and Ca2+-free media cultures was similar (Fig. 3.1D). This
suggests that PMA derived signals can prompt NK cell degranulation in a Ca2+independent manner.
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Extracellular Ca2+ entry is required for IFNγ expression but not for degranulation
and cytotoxicity by NK cells
To more rigorously assess the role of sustained extracellular Ca2+ entry in NK cell
function, we stimulated WT splenocytes with plate-bound antibodies against NK cell
activating receptors in the presence or absence of extracellular Ca2+. Compared to NK
cells stimulated in Ca2+-sufficient media, the proportion of NK cells expressing IFNγ was
severely reduced (80-90% inhibited) when activated in Ca2+-free media (Fig. 3.2A). In
contrast, the degranulation of NK cells activated in Ca2+-free media was relatively
preserved, ranging from a 15-40% decrease in the proportion of CD107a-expressing NK
cells, depending on the activating receptor. The decrease in the percentage of NK cells
expressing CD107a was not statistically significant following NK1.1 or NKG2D
stimulation but was significantly reduced following 2B4, Ly49D, and PMA/ionomycin
stimulation (Fig. 3.2A). Still, in general, there was relative preservation of the
degranulation response compared to IFNγ production in NK cells stimulated in Ca2+-free
conditions.
We next tested the role of extracellular Ca2+ entry in NK cell function using a genetic
approach. Although the initial burst of intracellular Ca2+ is controlled by IP3-mediated
release of Ca2+ from ER stores, sustained Ca2+ signaling requires extracellular Ca2+
mobilization through the CRAC channel that is controlled by the STIM1 and STIM2
proteins. We crossed STIM1fl/flSTIM2fl/fl mice to an NK cell-cre recombinase mouse—
NKp46icre—to generate mice deficient in both STIM1 and STIM2 proteins in mature NK
cells. STIM1fl/flSTIM2fl/fl-NKp46icre (STIM1/2 conditional double knockout; cDKO) mice
displayed similar splenic NK cell percentages, numbers, and normal NK cell
development compared to WT control mice (Fig. 3.3). STIM1/2 cDKO NK cells also
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expressed major NK cell activating receptors (NK1.1, 2B4, NKG2D, and Ly49D)
comparably to WT controls (Fig. 3.3). Similar to NK cells stimulated in Ca2+-free
conditions, STIM1/2 cDKO NK cells displayed significantly defective IFNγ production but
intact degranulation compared to WT NK cells upon stimulation with various activating
receptors and with PMA/Ionomycin (Fig. 3.2B-C). These data suggest that NK cell
cytotoxic function may be intact in the absence of SOCE.
A crucial step in NK cell-mediated cytotoxicity is the polarization of the microtubule
organizing center (MTOC) to the NK cell/target cell synapse

133,134

. Thus, we assessed

MTOC polarization of WT and STIM1/2 cDKO NK cells when co-cultured with the NK
cell-sensitive YAC-1 target cell. The polarization of the MTOC to the target cell synapse
was quantitatively similar between WT and STIM1/2 cDKO NK cells (Fig. 3.2D-E). The
preserved degranulation and MTOC polarization response correlated with intact
cytotoxic function of STIM1/2 cDKO NK cells, as STIM1/2 cDKO NK cells killed YAC-1
target cell as effectively as WT NK cells (Fig. 3.2F). Similarly, the cytotoxicity of WT and
STIM1/2 cDKO NK cells was comparable in a p815 target cell re-directed killing assay
using anti-NK1.1 antibody (Fig. 3.2G).
In T cells, STIM1 and STIM2 differentially contribute to downstream effector
functions. For example, STIM1-deficient T cells do not produce IL-2, IFNγ, and TNFα
71,131,132

, whereas STIM2-deficient T cells only have marginally reduced inflammatory

cytokine production. To test the relative contribution of STIM1 and STIM2 in NK cell
function, mice with NK cells lacking either STIM1 (STIM1 cKO) or STIM2 (STIM2 cKO)
were generated. Although STIM1 cKO NK cells to a large extent phenocopied STIM1/2
cDKO NK cells, STIM2 cKO NK cells displayed no statistically significant defect in IFNγ
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production or degranulation (Fig. 3.4), suggesting that STIM1 is the dominant isoform in
controlling SOCE during NK cell activation.

NK cells from STIM1/2 cDKO mice exhibit cytotoxic function in vivo
We next examined the capacity of STIM1/2 cDKO NK cells to mediate cytotoxicity and
clear tumor cells in vivo. We first tested the ability of STIM1/2 cDKO mice to acutely
clear RMA-S (TAP-deficient/MHC-Ilo, NK cell-susceptible) compared to parental RMA
(MHC-I+, NK cell resistant) tumor cells lines. We intravenously injected RMA:RMA-S
cells at a 1:3 ratio into WT, STIM1/2 cDKO, or NK cell-depleted WT animals and
measured how this ratio changed 18 hours post tumor challenge. As expected, the
RMA:RMA-S ratio skewed significantly towards RMA cells in WT mice compared to NK
cell-depleted WT mice (Fig. 3.5A). Although the RMA:RMA-S ratio was significantly
higher in STIM1/2 cDKO compared to WT mice, the ratio was still significantly lower than
that of NK cell-depleted WT mice, suggesting that STIM1/2 cDKO NK cells were capable
of acutely killing RMA-S cells in vivo (Fig. 3.5A). To measure long-term tumor growth
after tumor challenge, we subcutaneously injected equivalent numbers of RMA or RMAs cells into WT, cDKO, and NK cell-depleted WT mice. The tumor size of RMA-S cells
was smaller than RMA cells, which was normalized by NK cell depletion. Importantly, no
difference in tumor size was observed between WT and cDKO mice injected with either
RMA or RMA-S tumor cells, demonstrating that NK cells lacking STIM1/STIM2 limit
tumor growth comparably to WT controls (Fig. 3.5B). Together with our in vitro results,
these data strongly suggest that sustained Ca2+ entry through SOCE is dispensable for
NK cell degranulation and cytotoxic function.
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DAG-mediated signaling pathways drive NK cell degranulation in a transcriptionindependent manner
We next interrogated the mechanism behind why sustained mobilization of extracellular
Ca2+ was required for NK cell IFNγ production but not for NK cell degranulation. We
reasoned that IFNγ production might be defective in the absence of SOCE because the
induction of IFNγ but not degranulation requires the Ca2+-activated transcription factor
NFAT. To test this possibility, we blocked transcription by actinomycin D and more
specifically abrogated the activation of NFAT using a calcineurin inhibitor (Cyclosporine
A; CsA). Indeed, while the proportion of NK cells producing IFNγ was significantly
decreased in NK cells treated with actinomycin D or with CsA, these inhibitors had no
effect on degranulation, suggesting that degranulation does not require transcriptional
events (Fig. 3.6A).
The finding that SOCE is expendable for NK cell degranulation and cell-mediated
killing is surprising, but multiple Ca2+-dependent and independent pathways influence
this process

65,135-140

. Since DAG-derived signals were sufficient to drive NK cell

degranulation in the absence of extracellular Ca2+, we sought to determine the signaling
pathways downstream of DAG needed for NK cell degranulation when Ca2+-dependent
pathways were eliminated. DAG signals through three major downstream signaling
pathways that involve the activation of ERK, AKT, and PKC. To test the relative
contribution of these signaling pathways, we pharmacologically inhibited ERK (MEK
inhibitor U0126), AKT (AKT 1/2 inhibitor), and PKC (pan-PKC inhibitor Gö6983) in
splenocytes from WT and STIM1/2 cDKO mice that were stimulated with the anti–NK1.1
antibody. Following ERK inhibition using U0126, the proportion of STIM1/2 cDKO NK
cells expressing CD107a was higher than that of WT NK cells at each concentration,
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suggesting that WT NK cells rely on ERK for degranulation more than STIM1/2 cDKO
NK cells (Fig. 3.6B). AKT was equally required by WT and STIM1/2 cDKO NK cells for
degranulation (Fig. 3.6C). In contrast, cDKO NK cells were more sensitive to PKC
inhibition by Gö6983 compared to WT NK cells (Fig. 3.6D). This shows that in the
absence of sustained Ca2+ signaling, NK cells heavily rely on DAG-mediated PKC
activation for the degranulation response.
Our data indicate that in the absence of SOCE, NK cells have the ability to
degranulate and perform cell-mediated killing. Although sustained Ca2+ signaling is
required for IFNγ production in an NFAT-dependent manner, it is surprising that NK cellmediated killing is achievable in the absence of SOCE. This does not disqualify Ca2+
from being important to this process, as STIM1/2 cDKO NK cells undergo ER-mediated
Ca2+ release, have mitochondrial retention of Ca2+, and may express other Ca2+ channels
such as TRP channels

126

. What is clear from our data is that SOCE is not required for

NK cell killing as it is for CD8+ cytotoxic T cells 71,132.
Our data suggest that in the absence of SOCE, DAG-mediated signals alone are
sufficient to drive NK cell degranulation. PKC, which is directly activated by DAG, may
be critically important for degranulation in the absence of extracellular Ca2+ and
represents the minimal signaling requirement for NK cells to degranulate. It has been
shown that DAG-dependent signals drive microtubule-organizing center (MTOC) and
granule polarization in T cells

67,141,142

. That is in line with our data showing that STIM1/2

cDKO NK cells polarize their MTOC normally. Key synaptic and exocytosis proteins
depend on PKC for function. PKC isozymes phosphorylates the synaptic proteins
synaptotagmin, Syntaxin 4, VAMP, Munc18, and SNAP25, all which are critical for the
fusing of lysosomes to the plasma membrane and release of their contents
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143

. While

many of these proteins also have C2 Ca2+ binding domains, PKC isozymes may be the
chief factor in the final steps of NK cell degranulation. It is important to note that in
contrast to our mouse NK cell data, NK cells from human patients with ORAI1 and
STIM1 mutations are unable to degranulate. Interestingly, however, both human and
mouse NK cells do not require SOCE for the MTOC polarization process

98

. Thus, while

DAG-mediated signals also drive lytic granule docking and fusion in mouse NK cells,
human NK cells appear to require SOCE for these final steps of degranulation.
In summary, our data show that primary mouse NK cell degranulation and cellmediated killing does not depend on SOCE, and furthermore, point to DAG-mediated
downstream signaling molecules such as PKC as the key driver of this process. Our
studies show that degranulation, a key cell biological process that has been long thought
to be driven primarily by Ca2+ signals, can occur in the absence of sustained Ca2+ entry.
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Figure 3.1. PMA-driven signals cause NK cell degranulation. (A) Splenocytes were
unstimulated (unstim) or stimulated with PMA/ionomycin (PI), ionomycin alone, or PMA
alone for 6 hours. Representative flow cytometry plots of NK cell (NKp46+DX5+CD3- or
CD4/CD8-) CD107a and IFNγ expression are shown. (B) The fraction of CD107a and (C)
IFNγ expressing NK cells are represented as mean ± SEM of 4 independent
experiments (n=6 mice). (D) NK cells were stimulated with PMA alone in the presence
(MEM) and absence (Ca2+-free MEM) of extracellular Ca2+. The fraction of CD107a
expressing NK cells is represented as mean ± SEM of 3 independent experiments (n=36 mice). Significance for experiments was determined by Student’s t test *p<0.05,
**p<0.01, ***p<0.001, and ns= not significant.
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Figure 3.2. Sustained calcium signaling is critical for IFNγ production, but is not
required for NK cell degranulation and cytotoxicity. (A) WT splenocytes were
stimulated for 6 hours by plate-bound activating receptor antibodies in the presence
(MEM) or absence (Ca2+-free MEM) of extracellular Ca2+. The fraction of CD107a and
IFNγ-expressing NK cells are represented as mean ± SEM of 2 independent
experiments (n=4 mice). (B) Splenocytes from WT or STIM1/2 cDKO mice were
stimulated by (B) plate-bound activating receptor antibodies or (C) PMA/Ionomycin. The
fraction of CD107a and IFNγ-expressing NK cells are represented as mean ± SEM of 5
independent experiments (n=4-6 mice/genotype). (D) WT or cDKO DX5+ NK cells were
mixed 2:1 with CMAC-labeled YAC-1 cells (blue) in a conjugate assay and assessed for
MTOC polarization. Cell conjugates were stained for tubulin (green) and cathepsin D
(magenta) to visualize the MTOC and lytic granules, respectively. Representative
confocal microscopy images are shown. Scale bar is 5 µm. (E) NK cell MTOC distances
to the immune synapse (µm) are represented as mean ± SEM of >50 YAC-1: NK cell
conjugates (n=3 mice). (F) DX5+ NK cells from WT (black) and cDKO (white) mice were
co-cultured with luciferase+ YAC-1 cells or (G) luciferase+ p815 cells ± anti-NK1.1 in the
presence of rIL-2 for 6 hours at various E:T ratios. % specific lysis is shown as mean ±
SEM of 3 independent experiments (n=4 mice/genotype or condition). Statistics were
determined by using Student’s t test p<0.05, **p<0.01, ***p<0.001, and ns=not
significant. For all plots, Ly49D-stimulated NK cells are pre-gated on Ly49D+ NK cells.
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Figure 3.3. STIM1/2 cDKO and WT NK cells are phenotypically similar. (A) The
percent and (B) total number of splenic NK cells (NK1.1+NKp46+CD3ε−) from WT and
STIM1/2 cDKO mice were calculated and represented as mean ± SEM of 3 independent
experiments (n=4 mice/genotype). (C) Splenocytes were assessed for expression of
NK1.1, 2B4, NKG2D, and Ly49D. The MFI of each receptor expressed on splenic NK
cells (CD3ε-NKp46+DX5+ cells) are represented as mean ± SEM of 3 independent
experiments (n=4-5 mice/genotype).

61

Figure 3.4. STIM1 controls SOCE in murine NK cells. (A) Splenocytes from WT,
STIM1 cKO, or STIM2 cKO NK cells mice were stimulated with plate-bound activating
receptor antibodies for 6 hours. The fraction of CD107a and IFNγ-expressing NK cells
are represented as mean ± SEM of 3 independent experiments (n=3-5 mice/genotype).
For all plots, Ly49D-stimulated NK cells are pre-gated on Ly49D+ NK cells.
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Figure 3.5. STIM1/2 cDKO mice clear MHC-I deficient tumors. (A) WT, cDKO, and
NK cell–depleted WT mice were injected i.v. with a 1:3 ratio of CellTrace Violet-labeled
RMA and CFSE-labeled RMAS-S cells. 18 hours post injection, splenocytes were
analyzed for the presence of tumor cells by flow cytometry. The ratio of RMA-s:RMA
tumor cells within each mouse was calculated. Combined data from 2 independent
experiments is shown. Statistics were determined using paired student’s t test (p< 0.05,
**p<0.01, ***p<0.001, and ns=not significant). (B) RMA and RMA-S cells were injected
s.c. into WT, cDKO, or NK cell-depleted WT mice. Tumors were isolated and weighed
11 days post injection. Data is combined from 3 independent experiments. Statistics
were determined using student’s t test *p<0.05, **p<0.01, ***p<0.001, and ns=not
significant.
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Figure 3.6. DAG-mediated signaling pathways drive NK cell degranulation in a
transcription-independent manner. (A) WT splenocytes were stimulated by platebound activating receptor antibodies with DMSO (0.1%), CsA (1µM), or Actinomycin D
(5µg/mL) for 6 hours. The fraction of CD107a and IFNγ-expressing NK cells are
represented as mean ± SEM of 3 independent experiments (n=4-8 mice/condition). (B)
Splenocytes from WT and cDKO mice were stimulated with plate bound anti-NK1.1 for 6
hours with DMSO (0.1%) or various concentrations of U0126 (MEK inhibitor), (C) AKT
inhibitor (AKTi), or (D) Gö6983 (pan-PKC inhibitor). The percentage of CD107a
expressing cells compared to DMSO controls (percentage of baseline) is plotted as
mean ± SEM of 5 independent experiments (n=4–6 mice/concentration). Significance
was determined by paired Student’s t test *p<0.05, **p<0.01, ***p<0.001, and ns=not
significant.
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CHAPTER IV: DISCUSSION
In this thesis, I examined the contributions of NK cell activating receptor signaling
pathways to NK cell development and effector function.

In Chapter II, I describe a

mechanism by which NK cells generate diversity and create target cell specificity. Ly49
receptors, the functional orthologs of KIRs in humans, generate vast diversity for the
murine NK cell population. I determined that SLP-76-dependent activation signals are
required for NK cell Ly49 receptor expression. SLP-76 proximal signaling proteins,
LAT1/LAT2 and ADAP, differentially affect Ly49 family member expression. These
pathways have been shown to initiate expression of different transcription factors that
may ultimately affect the transcriptional landscape of the Ly49 receptor genes. SLP-76
regulates Ly49 transcription by regulating the switch function of the Pro1 bi-directional
promoter region in immature NK cells. In Chapter III, I demonstrate that while NK cells
require sustained Ca2+ entry (mediated by STIM1/2) for IFNγ production, NK cells are
able to degranulate and perform cell-mediated killing without SOCE. This is a novel
finding, as it has been reported that cytotoxic CD8+ T cells and even human NK cells
may need SOCE following immunoreceptor activation for cytotoxic function. While this
work sheds new light on two major subjects of interest to the NK cell field, it provokes
new questions that require further experimental investigation.
Different activating receptors for acquisition of different inhibitory receptors
I utilized SLP-76 KO mice, which have defective NK cell signaling, to test if Ly49
receptor acquisition during NK cell development depended on activation through NK cell
activating receptors. NK cells express not only a variety of inhibitory receptors, but also
a variety of activating receptors.

For example, all murine NK cells express NK1.1,
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NKG2D, 2B4, DNAM-1, CD2, and the natural cytotoxicity receptors NKp46 and NKp30.
Even 50% of murine NK cells express the activating receptors Ly49D and Ly49H. The
majority of these activating receptors are expressed early in hematopoiesis and serve
not only as activating receptors, but also as protein markers for identifying NK cells by
flow cytometry. Although all of the receptors listed converge on SLP-76, they differ in the
adaptor molecules they use for signaling. For example, NKG2D is phosphorylated on
YNIM motifs on the cytoplasmic tail of the receptor. CD16 signals using ITAM motifs of
CD3 zeta chains

144

. Because of these differences in signaling adaptors, different

downstream signaling pathways and transcription factors may be activated.
I showed that LAT1/LAT2 and ADAP signaling pathways contribute differentially
to Ly49 receptor expression, and I suspect different NK cell activating receptors
preferentially activate one pathway or the other. While both ITAM-mediated and other
adaptors (e.g. SAP-mediated) can lead to both LAT1/LAT2 and ADAP downstream, it is
possible the ADAP pathway preferentially is activated over LAT/LAT2 following
stimulation with 2B4. 2B4 signals through the SAP-Fyn axis,. The src kinase Fyn is able
to engage ADAP and initiate its signaling cascade

51,145

, which could lead to Ly49G2

expression. Furthermore, because NK cells require 2B4 co-stimulation for maximal
effector function

72,146

, the NK cell may be more likely to require integrin signals, which

would preferentially initiate ADAP activation through outside-in-signaling.
It is also possible that certain activating receptors are not the directing agents for
determining LAT1/LAT2 vs ADAP signaling pathway usage. It could very well be a
protein concentration or protein localization problem. What concentration of LAT or
ADAP protein is available to bind to SLP-76 the time of stimulation? Studies examining
how those pathways are preferentially activated and their relative contribution to the
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Pro1 transcriptional landscape are, in my opinion, the next step to understanding SLP76’s role in Ly49 Pro1 regulation.

SLP-76 and the Pro1 bi-directional switch: Does it open up the playing field or
just send the players?
In Chapter II of my dissertation, I shed light on the role of SLP-76 in regulating the bidirectional Ly49G Pro1 promoter region during early NK cell development. Pro1 is active
in developing NK cells and is thought to be regulated by transcription factors that bind
upstream of a TATA box region. I discovered that SLP-76 is critical for driving forward
transcription off the Pro1 promoter and it blocks reverse transcription. I, and others, have
generally believed that transcription factors activated downstream of SLP-76 are the
regulating factors over Pro1. My finding that SLP-76 KO NK cells have reduced H3K9 at
Pro1 compared to controls is the first evidence of epigenetic modifications found to
control Pro1, which may suggest another role for SLP-76 in early Ly49 receptor
transcription.
The Pro2 region is regulated by epigenetic modifications, including DNA
methylation and histone acetylation. Interestingly, while WT and SLP-76 KO NK cells
showed a similar amount of H3K9 acetylation at Pro2 (even with a 90% reduction in
Ly49 expression in mature NK cells), I found H3K9 acetylation at the Ly49G Pro1 region
in splenic WT NK cells and a reduction of this open chromatin mark in SLP-76 KO NK
cells. This is a puzzling finding, as it has been published

46,117

that Pro2 acetylation in

mature NK cells equates with open chromatin at the locus and expression of Ly49s. In
2016, Stephen Anderson’s group published an elegant study challenging work done by
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Colin Brook’s laboratory in 2015. Anderson’s group cited that the Ly49 Pro1 region is not
an enhancer region for Pro2

42,117

. Anderson’s team provided evidence that Pro1 is not

active in mature NK cells as Brook’s group had claimed, but if not, what is the functional
meaning of my H3K9 Pro1 acetylation in immature NK cells?
First, H3K9 acetylation at Ly49G Pro1 could just be an indicating marker of Ly49
protein expression. If the chromatin at Pro1 was accessible for transcription during early
development, there is protein expression in mature NK cells, which may be regulated
through DNA methylation rather than histone acetylation at Pro2. Secondly, our data
could point to the novel finding that SLP-76 assists in opening the chromatin landscape.
SLP-76 may drive the activation of a/the histone acetyltransferase that acetylates H3K9
at Pro1. If this is the case, then perhaps the role of SLP-76 activation signals is to
promote

epigenetic

modifications

of

the

Ly49

promoter

rather

than

activate

transcriptional programs that bind to sense and antisense DNA strands on Ly49 genes.
Finally, SLP-76 dependent signals could contribute to both open chromatin landscape as
well as regulating transcription factors that bind at the Pro1 promoter region. It would be
difficult to block SLP-76 downstream pathways to assess transcription factors binding to
Pro1 promoter regions, as there is so much redundancy from the variety of activating
receptors that can be stimulated, the cytokine signaling pathways that interface or
activate the pathways independently, etc. It would be easy to test SLP-76’s contribution
to H3K9 acetylation using an in vitro NK cell differentiation assay. By transducing SLP76 shRNA or scramble shRNA into hematopoietic stem cells, NK cells could be
developed in vitro using the OP-9 stromal cell line to generate Ly49 receptor-expressing
NK cells

20

. We could then treat the developing NK cells with a histone deacetylase

(HDAC) inhibitor to see if SLP-76 knockdown NK cells were able to increase expression
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of Pro1 forward transcripts. Results of this experiment may reveal whether or not SLP76 is just required for transcription factor binding to Pro1 or potentially more. If HDAC
inhibition of developing NK cells resulted in an increase of Ly49G Pro1 forward
transcripts, it would tell us that SLP-76 is needed for Pro1 chromatin accessibility rather
than SLP-76 dependent transcription factors. HDAC inhibition may cause extensive
problems for multiple loci, in which case we would want to genetically alter the Pro1
locus by ensuring constitutive histone acetylation at Pro1 and then looking for SLP-76’s
contribution to the transcriptional landscape.

Role of DAG and IP3 signaling pathways in Ly49 receptor acquisition
As I have described in detail, SLP-76 is an adaptor molecule downstream of NK cell
activating receptors that binds PLCγ. PLCγ hydrolyzes PIP2 into the second messengers
DAG and IP3. Therefore, if SLP-76 is critical for Ly49 receptor acquisition during NK cell
development, one or both of these downstream pathways should contribute to the
expression of the Ly49 inhibitory receptors. Published work on NK cells that are deficient
in a negative regulator of DAG signaling, diacylglycerol kinase zeta (DGKζ), had normal
percentages of NK cells expressing inhibitory receptors of the Ly49 receptor family

65

.

This data suggests that transcription factors downstream of DAG signaling may not
contribute to the Ly49 Pro1 promoter region. If increased DAG-signaling does not
increase Ly49 receptor-expressing NK cells, it may suggest that these percentages of
Ly49 receptor-expressing NK cells are fixed or that IP3 signaling and SOCE influence
Ly49 receptor expression.
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I bred STIM1flox/floxSTIM2flox/flox animals to VavCre+ mice to generate STIM1/2
cDKO animals in which all hematopoietic cells were deficient in STIM1 and STIM2. I was
unable to use the NKp46icre mice for Ly49 receptor phenotyping, as deletion of STIM1
and STIM2 would occur too late in the Ly49 receptor acquisition process (which begins
at the same time NKp46 expressed on NK cells). As NK cells regulate Ly49A, Ly49G2,
and Ly49I intrinsically, we were able to assess these receptors with confidence in a
VavCre model. STIM1/2 cDKO NK cells had mildly reduced Ly49 receptor-expressing
NK cells, but did not phenocopy SLP-76 KO NK cells (Data Not Shown). The most
affected NK cell populations were Ly49A and Ly49G2 expressing cells. In particular,
there was a 50% reduction in the percentage of NK cells expressing Ly49A.
The Ly49 receptors are located next to each other in an NK cell cluster on
chromosome 6. Perhaps since Ly49A is the first Ly49 to be acquired on an NK cell’s
surface, a large activating signal is required to initiate the transcription of this family of
genes. It is plausible that because all the Ly49 genes sit next to each other, one
activation signal is enough to open/unwind the chromatin of this region.

A large

activation signal through activating receptors could result in the mobilization of
extracellular Ca2+ into the cytoplasm. A large influx of Ca2+ might be a signal required for
opening of the transcriptional landscape, perhaps through histone acetylation at Pro1
Ly49A. While each Ly49 has its own Pro1 promoter, there may be different histone
marks that open a region of he Ly49 gene cluster vs specific promoter regions of
individual Ly49 genes. It is puzzling that while SLP-76 KO NK cells have no Ly49G2
receptor expression and reduced Ly49G Pro1 forward transcripts, DGKζ

-/-

NK cells and

STIM1/2 cDKO NK cells have normal Ly49G2 expression as DAG and IP3 are the two
main pathways downstream of SLP-76. Perhaps, SOCE through STIM1 and STIM2 is
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not required for Ly49 receptor transcription, but rather other Ca2+ sources through TRPC
receptors or even ER release of Ca2+ is enough to activate the Pro1 promoter region.
One could test ER release on this process by developing NK cells in vitro (as proposed
earlier) and using SERCA pump inhibitors to block this release. There is a chance that
long-term treatment with such inhibitors would cause other channels to open. Another
approach might be to knockdown IP3R using an shRNA to see if it would inhibit Pro1
forward transcripts of Ly49G-expressing NK cells.

PKC regulation of NK cell degranulation
During my doctoral research I generated further preliminary data where the role of
SOCE in NK cell degranulation is unclear. Although primary murine NK cells do not
require SOCE for NK cell degranulation and cytotoxicity, IL-2 expanded NK cells, also
known as LAKs, do. Following stimulation with plate-bound antibodies against NK cell
activating receptors, STIM1/2 cDKO LAKs were unable to express CD107a on their cell
surface. Furthermore, STIM1/2 cDKO LAKs did not kill YAC-1 target cells, even at the
highest NK cell to target ratio—40:1 (Appendix II).

This was a surprising finding

specifically because we determined in Chapter III that MTOC and cytotoxic granule
polarization) is intact in STIM1/2 cDKO NK cells. In fact, STIM1/2 cDKO LAKs also have
normal MTOC polarization (Data Not Shown). Normal polarization of the MTOC but
reduced killing in STIM1/2 cDKO LAKs points to the processes of granule fusing,
docking, or release as a STIM1/2-dependent process in IL-2-expanded LAKs.

This

finding did not apply to all cytokine expanded NK cells, as polyI:C activated STIM1/2
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cDKO NK cells (expanded through up-regulation of Type I interferons) preserved their
ability to degranulate following activating receptor-mediated stimulation (Appendix III).
In Chapter III, I demonstrate that PMA, a chemical analog of DAG, induces the
expression of CD107a on primary murine NK cells. Furthermore, inhibitor data suggests
that PKC activation contributes to SOCE-independent degranulation. This finding is
substantiated by previously published research on the role of PKC and T cell
degranulation as well as my own preliminary experimental findings. PKC isozymes are
critical for degranulation and killing of tumor cells

139,140,147,148

. Based on what is known

about DAG signals driving PKC activation at the plasma membrane, I suspect that PKC
might be critical for proteins critical to vesicle docking, fusion, or release141,143. PKC
family members differ in their requirement for Ca2+ binding.

There are three Ca2+-

dependent PKCs (PKCα and PKCβI and II) and multiple Ca2+-independent isozymes
(e.g.PKCθ and PKCδ). Blocking the Ca2+-dependent PKCs using the inhibitor Gö6979,
which selectively inhibits PKCα and PKCβI, blocks NK cell degranulation in primary
murine NK cells (Data not shown). This might suggest that Ca2+-dependent PKCs are
needed for NK cell cytotoxicity, implying a role for Ca2+ in the process.

Although it

seems at odds, this finding may still be in line with my STIM1/2 cDKO NK cell data.
Because STIM1/2 cDKO NK cells release Ca2+ from the ER stores into the cytoplasm,
that Ca2+ could be enough to trigger Ca2+-dependent PKC activation. In preliminary
experiments, I found that treatment of primary murine NK cells with the IP3 inhibitor 2APB (2-Aminoethoxydiphenyl borate) dramatically reduced the percentage of CD107a+
NK cells after stimulation through activating receptors 149.
On the other hand, DAG signaling directly activates PKC, and could be the chief
driver of NK cell degranulation regardless of the presence of Ca2+. PMA stimulation of
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primary murine NK cells causes them to degranulate. PMA stimulation of WT LAKs
does not induce degranulation, a finding that has stumped NK cell biologists for
decades. This observation has never been given proper investigation, but when my
preliminary data suggested that LAKs require sustained Ca2+ for degranulation, I
examined if NK cells express different amounts of PKC isozymes.

I originally

hypothesized that LAKs might utilize Ca2+-dependent PKCs for degranulation while
primary NK cells utilized Ca2+-independent PKCs.

Surely enough, multiple PKC

isozymes are down-regulated in LAKs (PKCθ,α,δ, βI) as assessed by western blot and
an initial qPCR experiment (Data Not Shown), which may be why these cells are unable
to degranulate upon PMA stimulation. Furthermore, without PKCs, the LAKs may not be
able to initiate CD107a expression on NK cells following activating receptor stimulation,
while PKC-expressing primary NK cells can. These initial observations are intriguing and
might uncover differences in how NK cells use PKC-dependent pathways to initiate the
degranulation of lytic granules.

It is conceivable that NK cells even require PKC

isozymes at different stages of target cell recognition and cytolysis than their T cell
counterparts. These questions will be explored in the lab after my departure.

Applications of this research to NK cells in the clinic
The research in this dissertation adds a great deal of knowledge to the NK cell field
about signaling pathways that govern both NK cell development and effector function.
While the current state of the research is just starting to branch out of murine models
into human NK cell work, there are many exciting ways in which my research could
impact the future directions of using NK cells as therapeutics, specifically in the settings
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of cancer. Although not a usable model in the clinic now, clinician scientists are able to
grow fully functional NK cells outside the body from CD34+ fetal cord blood. In parallel,
researchers are improving ways to genetically modify NK cells using lentiviral techniques
and electroporation. The research on signaling pathways that govern inhibitory receptor
acquisition in early NK cell development could help design personalized KIR repertoires
for patient benefit. During NK cell differentiation from CD34+ cord blood, cells may be
manipulated through activating or inhibiting certain signaling pathways (lentiviral
transduction or commercially available inhibitors).

Depending on what signals are

received, this could influence the inhibitory KIR receptors that are expressed.
Additionally, if a situation of KIR-negativity was required on allogeneic NK cells for retransplantation, lentiviral knockdown of SLP-76 could be used to generate a KIRpopulation.
NK cells are often re-infused into patients following bone marrow transplant
(BMT) or organ transplant as a way to fight off residual cancer cells.

With

transplantation though, comes treatment of patients with many immunosuppressive
drugs that alter major signaling pathways not only in NK cells but also T cells. This is to
blunt the activation of T cells in hopes of eliminating symptoms of GVHD. These drugs
and inhibitors will ultimately affect the repertoire of inhibitory receptors on NK cells,
which could be problematic for tumor cell clearance or viral infection clearance. The
information this dissertation research adds to the NK cell field’s knowledge of influences
on

inhibitory

receptor

repertoire

may

guide

clinicians

to

different

types

of

immunosuppressants or different timings to positively impact NK cell repertoire.
Lastly, research showing NK cell cytotoxicity in the absence of SOCE is
important, novel information for the same reason as above. Immunosuppressive drugs,
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like cyclosporine A, block effects of SOCE like NFAT activation. Short term, this has no
impact on NK cell degranulation as it is a transcription-independent process. There is a
great potential that through DAG-mediated signaling, and even in an environment with
suppressed SOCE, NK cells are able to function through cell-mediated killing to
eliminate target cells. This will most likely be most applicable to cancer, as inflammatory
cytokine recruitment of T cells is extremely important for clearance of viral infection, but
the benefits will be important for all NK cell target cells.
In conclusion, the work presented in this thesis demonstrates that activation
signals through NK cell activating receptors initiate transcription of Ly49 or KIR inhibitory
receptors on NK cells. The repertoire of inhibitory receptors is critical for NK cell function
and recognition of target cells. Additionally, this work demonstrates that NK cells may
not need sustained Ca2+ signals to perform all their important effector functions, such as
degranulation. Ca2+-independent signals, through DAG, are sufficient to drive NK cell
degranulation and the cell-mediated killing of target cells. NK cells are still a young and
mysterious cell type, so many questions remain as to how they function, what controls
their development, and how can clinicians and research scientists manipulate them for
patient benefit. Further studies will be required to answer remaining questions about NK
cell signaling and transition our knowledge of these signaling impacts on the NK cell
population into clinical therapies.
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APPENDIX I

A) Ly49 Pro1 Forward Transcription– Ly49 expression
Histone Acetylation
No Pro2 DNA methylation

PRO1 FORWARD
TRANSCRIPTION

Pro2

Pro1

Ly49
Expression
Ly49

B) Ly49 Pro1 Reverse Transcription– No Ly49 expression

Pro1

X

CH3 CH3 CH3
Ly49
Pro2

PRO1 REVERSE
Transcription

APPENDIX I: Regulation of Ly49 receptor transcription by two promoter regions.
A) The Pro1 promoter region is active in immature NK cells and is a bi-directional
promoter that is regulated by transcription factors. When transcription factors bind to
Pro1 on the sense DNA strand, the Pro2 promoter (active in mature NK cells) opens.
Histone acetylation occurs at Pro2 as well as the active demethylation of Pro2 DNA.
This leads to Ly49 receptor gene expression. This is forward transcription. B) If
transcription factors bind on the anti-sense strand in a different confirmation than what
binds to the sense DNA strand, reverse transcription occurs. Histones at Pro2 remain
unacetylated and the DNA is highly methylated, resulting in no Ly49 receptor
transcription and subsequent protein expression.
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APPENDIX II

APPENDIX II: IL-2-expanded NK cells (LAKs) require SOCE for degranulation and
cytotoxicity. (A) WT or STIM1/2 cDKO DX5+ splenocytes were MACS purified and
expanded in vitro with 1000U/mL human recombinant IL-2 for 5-6 days. LAKs were
rested in IL-2-free media for 2 hours and then were stimulated for 6 hours by platebound activating receptor antibodies. The fraction of CD107a and IFNγ-expressing NK
cells are represented as mean ± SEM of n=3-4 mice. (B) WT (black) and STIM1/2 cDKO
(white) LAKs (rested for 2 hours without IL-2) were co-cultured with luciferase+ YAC-1
cells at various E:T ratios. % specific lysis is shown as mean ± SEM n= 3 mice/genotype
or condition. Statistics were determined by using unpaired (A) or paired (B) Student’s t
test p<0.05, **p<0.01, ***p<0.001, and ns=not significant. Ly49D-stimulated NK cells are
pre-gated on Ly49D+ NK cells.
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APPENDIX III

APPENDIX III: Poly(I:C) activated STIM1/2 cDKO NK cells degranulate following
activating receptor stimulation. (A) WT or STIM1/2 cDKO mice were i.p. injected with
250µg polyinosinic-polycytidylic acid [poly(I:C)]. 18 hours after injection, splenocytes
were harvested and stimulated for 6 hours by plate-bound activating receptor antibodies.
The fraction of CD107a and IFNγ-expressing NK cells are represented as mean ± SEM
of n=4 mice. Statistics were determined by using Student’s t test p<0.05, **p<0.01,
***p<0.001, and ns=not significant. Ly49D-stimulated NK cells are pre-gated on Ly49D+
NK cells.
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APPENDIX IV: Materials and Methods
Mice
Mice were housed in pathogen-free conditions and treated in strict compliance with the
Institutional Animal Care and Use Committee regulations at the University of
Pennsylvania. In Chapter II: C57BL/6 (CD45.2+), B6.SJL (CD45.1+), and β2m KO mice
were purchased from The Jackson Laboratory or Charles River Laboratories. LAT1/2
DKO, ADAP KO, and SLP-76 KO mice have been previously described and were bred in
our facility

150-152

. SLP-76 KO mice have been ~3 times backcrossed to C57BL/6 mice

due to embryonic lethality of fully backcrossed mice and thus, littermate controls were
used for all experiments. LAT1/LAT2/ADAP TKO mice were generated by crossing
LAT1/2 DKO mice to ADAP KO mice. SLP-76.B10D2 KO mice were generated by
crossing B10.D2 mice to SLP-76 KO mice and screening for H-2d alleles. All mice were
sacrificed and analyzed between 10-12 weeks of age.

In Chapter III: STIM1flox/flox

STIM2flox/flox mice were generated and generously provided by Dr. Anjana Rao, La Jolla
Institute for Allergy and Immunology (LIAI), Dr. Patrick Hogan, LIAI, and Dr. Masatsugu
Oh-hora, Kyushu University,
153
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. These animals were bred to NKp46iCre/wt transgenic mice

. Age-matched littermate or vendor purchased C57BL/6 (WT) control animals were

used for all experiments using STIM1flox/flox STIM2flox/flox (cDKO), STIM1 cKO, and STIM2
cKO mice. Mice were sacrificed and analyzed between 8–12 weeks of age.

Reagents
For Chapter II: All reagents were purchased from Sigma-Aldrich (St. Louis, MO) and
unless otherwise specified. Cytokines were purchased from Peprotech (Rocky Hill, NJ).
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Antibodies (Abs) for cell stimulation were purchased from BioXcell (Malaysia) or
Biolegend. Abs for flow cytometry were purchased from Biolegend, eBiosciences, BD
Biosciences, and Molecular Probes. The following Ly49 receptor antibodies/clones were
used: Anti-Ly49A (YE1/48.10.6), anti-Ly49G2 (4D11), anti-Ly49I (YL1-90), anti-Ly49D
(4E5), anti-Ly49H (3D10), and anti-Ly49C/I (5E6) from BD Pharmigen. Anti-Ly49C
(4LO3311) was purchased from the UCSF Cell Culture Facility (San Francisco, CA). For
Chapter III: Antibodies for NK cell stimulations, phenotyping, and MACS purification
were purchased from BD Pharmingen (San Diego, CA): NK1.1 APC (PK136), CD244.2
Biotin (2B4), purified Ly49D purified (4E5), and CD4 Pacific Blue (RM4-5); BioLegend
(San Diego, CA): CD8 BV421 (53-6.7), CD49b Biotin (DX5), CD107a PE (1D4B), and
Streptavidin BV421; eBioscience (San Diego, CA): CD3ε FITC (17A2), CD3ε APCeFl780
(145-2C11), NKp46 PerCPeFl710 (29A1.4), CD49b FITC (DX5), IFNγ PE-Cy7
(XMG1.2), NKG2D APC (CX5), and Ly49D APC (4E5); BioXcell: purified NKG2D
(HMG2D) and purified NK1.1 (PK136); and Molecular Probes, Invitrogen (Carlsbad, CA):
Live/Dead Aqua or Near-IR. Antibodies used for confocal microscopy: Rat anti-alpha
tubulin (clone YL1/2, Serotec), goat anti-Cathepsin D (R&D systems AF1029), CMAC
(Invitrogen), Alexa Fluor 488 donkey anti-rat IgG (Invitrogen A21208), Alexa Fluor 568
donkey anti-mouse IgG (Invitrogen A10037), and Alexa Fluor 647 donkey anti-goat IgG
(Invitrogen A21447). Inhibitors:

Akt Inhibitor VIII, Isozyme-Selective, Akti-1/2 was

purchased from Calbiochem (Darmstadt, Germany).

Gö6983 was purchased from

Tocris Bioscience (Bristol, United Kingdom). U0126 was purchased from Cell Signaling
(Danvers, MA). Cyclosporine A and Actinomycin D were purchased from Sigma (St.
Louis, MO). Inhibitors were reconstituted following manufacturer’s instructions.
Flow cytometry, cell sorting, and data analysis
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Cells were stained with antibodies against cell-surface antigens and LIVE/DEAD cell
stain at 4°C for 20 minutes. Intracellular staining was performed using the
Cytofix/Cytoperm Fixation and Permabilization Kit (BD Pharmingen) per manufacturer
instructions. Flow cytometry was performed with a FACS Canto flow cytometer (BD
Biosciences), and cell sorting was performed using a FACSAria (BD Biosciences). Data
were analyzed with FlowJo software (TreeStar, Ashland, OR) and Simplified
Presentation of Incredibly Complex Evaluations (SPICE- NIAID, Bethesda, MD).
Statistical analysis was performed using Prism (GraphPad, San Diego, CA) computer
software.

Primary NK cell cultures and stimulations
Total splenocytes were plated in 96-well plates in NK-cell media (MEMα [Invitrogen]
supplemented with 10% FBS, 1% penicillin/streptomycin, 10 mM HEPES and 1 x 10−5 βME) with human IL-2 (1,000 U/mL) on plate-immobilized (20 µg/mL) anti-NK1.1, antiNKG2D, anti-CD244, anti-Ly49D or with soluble PMA (100 ng/mL), ionomycin (1 ug/mL)
or a combination of both in the presence of monensin (eBiosciences) and anti-CD107aPE for 6 h at 37°C. For experiments using Ca2+-free media, splenocytes were plated in
either Ca2+-sufficient media (MEM with 10% FBS, 1% penicillin/streptomycin, 10 mM
HEPES and 1 x 10−5 β-ME) or Ca2+ free media (S-MEM with 10% FBS, 1%
penicillin/streptomycin, 1% L-Glutamine, 250uM EGTA, 10 mM HEPES and 1 x 10−5 βME). Following stimulation, splenocytes were assessed using flow cytometry and gated
on live, singlet NK cells (CD3ε-NKp46+DX5+) unless described otherwise and assessed
for CD107a and intracellular IFNγ expression.
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Generation of mixed BM chimeras
SLP-76 KO (CD45.1+) bone marrow (BM) cells were T/NK cell depleted by CD3 and
NK1.1 magnetic bead depletion (Miltenyi Biotec). T/NK-cell depleted BM cells from
CD45.1+CD45.2+ wild-type (competitor) mice were mixed at a 2:1 ratio with the SLP-76
KO BM. Cells were injected intravenously into lethally irradiated (950 cGy) CD45.2+
recipient mice. Mixed BM chimeric mice were analyzed by flow cytometry 10-12 weeks
post injection.

RT-PCR
RNA was purified from equivalent cell numbers of sorted splenic and BM NK cells
(RNeasy kit-Qiagen). cDNA synthesis was performed using SuperScript II Reverse
Transcriptase (Invitrogen) kit and performed using manufacturer’s instructions. Primers
for SLP-76, Ly49G2, and Ly49I (Applied Biosystems) were used. The reaction was
performed on the Applied Biosystems StepOnePlus Real Time PCR System (Carlsbad,
CA), and ΔΔ-CT method was employed. Results were normalized to the housekeeping
gene GAPDH.

RT-PCR of Ly49G2 Pro1 Transcripts
Total RNA was purified from 100,000 sorted cells with the RNeasy Micro Kit (Qiagen),
and cDNA synthesis was carried out using Random Hexamer primer, Taqman Reverse
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Transcription Reagents kit (Applied Biosystems) according to the manufacturer’s
instructions. The primers used in the Ly49-specific qRT-PCR assay were: Ly49g-Pro1
forward primer (5′-CAAGTGATCAGCCTATTCTTGTG-3′); Ly49g-Pro1 reverse primer
(5′-CTTGTGTGAGTTTTGTACTTCAG

-3′);

Ly49g-Pro1as

CACTGCCTTATATGCCTAAACAC-3′);

Ly49g-Pro1as

GACTTCATGACTAGTTACTGG-3′);

β-Actin

CCTGGCACCCAGCACAAT-3′);

and

β-Actin

forward
reverse

forward
reverse

primer
primer

primer
primer

(5′(5′(5′(5′-

GGGCCGGACTCGTCATACT-3′). Reactions were carried out using the FastStart SYBR
Green Master kit (Roche Diagnostics, Indianapolis, IN, USA) on the 7300 Real-Time
PCR System (Applied Biosystems). The qRT-PCR was performed in duplicate and was
repeated in at least three separate experiments using the following conditions. Reaction
mixtures contained 12.5µL of SYBR Green master mix, 2 pmoles each of forward and
reverse primers and 5 ng cDNA. Thermocycler conditions included initial denaturation at
50 and 95 °C (10 min each), followed by 40 cycles at 95 °C (15 s) and 60 °C (1 min).
Melting curve analyses were performed to verify the amplification specificity. Relative
quantification of gene expression was performed according to the ΔΔ-CT method using
the StepOne Software 2.0 (Applied Biosystems). The results were normalized to the
housekeeping gene β-Actin.

Chromatin Immunoprecipitation (ChIP)
WT and SLP-76 KO splenic NK cells (CD3ε −NK1.1+NKp46+DX5+) were sorted by flow
cytometry, cross-linked for 10 min with 1% formaldehyde in cold PBS buffer, and
subsequently quenched with 125 mM glycine for 5 min. The cells were pelleted by
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centrifugation at 470× g for 10 min and washed with PBS containing protease inhibitor
cocktail. After centrifugation, the supernatant was discarded, and the cell pellet was
stored at −80°C. DNA shearing was performed with a chromatin immunoprecipitation
enzymatic shearing kit (Chromatrap, Ashland, VA) following the manufacturer’s
instructions. Immunoprecipitation was performed with the True MicroChIP kit
(Diagenode, Denville, NJ, USA) using a CHIP grade antibody against H3K9ac
(Diagenode). A non-specific rabbit IgG was used as a negative control. All ChIP steps
were performed in Eppendorf 1.5-ml DNA LoBind Tubes (Eppendorf, Hamburg,
Germany). The specific primer sequences used in ChIP-qPCR were as follows: Ly49g
Pro-1,

forward,

5’-

CCCATCAAGGACTATGTGTTTAGG-3’,

ATGGTAAACTTCACAGATCTTAGG-3’;

Ly49g

CACAGGAATCACTTCTCAGTAGA-3’,reverse,
3’;Ly49e

Pro-2,

forward,

Pro-2,

reverse,5’-

forward,

5’-

5’-ATCGAGCGCTCACATAACACTAT-

5’-GCAATTTCCTCCTTTTGCTTAGATA-3’,reverse,

5’-

TGGAGGGAAAAGTTGGGTGAAA-3’. The precipitated DNA fractions were quantified by
real-time PCR with the FastStart Universal SYBR Green Master Kit (Roche Diagnostics,
Indianapolis, IN, USA) using 7300 Real-Time PCR System; (Applied Biosystems). The
results were normalized as the percentage of the input (%input) from Ct values. The
experiments were repeated three times.

CD34+ cell retroviral transduction and in vitro development
The use of all human tissue was approved by the Committee on the Use of Human
Subjects in research at that University of Minnesota (Minneapolis, MN), and informed
consent was obtained in accordance with the Declaration of Helsinki. Lentivirus
containing either scramble control or SLP-76 shRNA in pGIPZ vectors was packaged in
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293T cells using PAX2 and pMDG.2 plasmids (Open Biosystems, Lafayette, CO). A pool
of four SLP-76 shRNA vectors (clones V2LHS_62885, V3LHS_364697, V2LHS_62886
and V3LHS_364699) was used. CD34+ hematopoietic cells were isolated from umbilical
cord blood by double-column positive selection using anti-CD34 microbeads (Miltenyi
Biotec). Cells were transduced with lentivirus by spin transduction, and CD34+GFP+ cells
were sorted. CD34+GFP+ cells were cultured for 21 days on the EL08-1D2 fetal stromal
line

154

. The culture media and cytokines used for human NK cell differentiation are

published 155.

Immunofluorescence Microscopy and MTOC Measurements
YAC-1 cells were labeled with 20 µM CMAC in serum-free RPMI (Gibco) for 30 minutes
at 37 degrees, washed twice with 10% FBS RPMI, and mixed 1:2 with NK cells in
polypropylene round-bottom tubes in serum-free RPMI. Conjugation was induced by
centrifugation for 5 minutes. Pelleted cells were incubated together for 10 minutes,
gently suspended, added to Poly-L lysine coated 12-mm coverslips to adhere for 10
minutes. Cells were subsequently fixed with 3% paraformaldehyde in PBS, quenched,
permeabilized with 0.1% Triton X-100, and blocked in PBS with 0.01% saponin and
0.25% gelatin (PSG). Cells were stained with primary antibodies in PSG, washed 5
times with PSG, stained with secondary antibodies in PSG, washed an additional 5
times with PSG, washed once with milli-Q H2O, and mounted on slides with mowiol
mounting media (Sigma Aldrich). Cell conjugates were imaged using a 63x PlanApo 1.4
NA objective on an Axiovert 200 (Carl Zeiss) equipped with a spinning disk confocal
system (UltraView ERS 6; Perkin Elmer). Images were collected using an ORCA-ER
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camera

(Hamamatsu

Photonics)

using

Volocity

acquisition

software

(v6.1.1;

PerkinElmer). MTOC to synapse measurements were performed manually as follows:
the border of the YAC-1 cell was determined on an experimental basis based on CMAC
fluorescence intensity. The MTOC was defined as the pixel with the brightest intensity in
the 488 channel (anti-tubulin). MTOC to synapse measurement is the distance from the
MTOC pixel to one pixel within the YAC-1 border. All measurements were made with
Volocity imaging software. Image preparation was performed with ImageJ.

Bioluminescent Cytotoxicity Assay
Splenocytes from STIM1/STIM2 cDKO or control mice were stained with bioyinylated
anti–DX5 antibody and enriched using anti-biotin MACS beads (Miltenyi Biotec).
Luciferase-expressing target cells (Yac-1 or P815) were incubated at various effector to
target (E:T) ratios with DX5+-enriched splenocytes for 6 hours at 37°C in the presence of
1000 U/mL human recombinant IL-2 as previously described

156

. For the P815 target

cells, anti-PK136 (NK1.1) was added at 5 µg/mL for re-directed lysis prior to effector cell
plating. Lucerifase activity was detected using the IVIS Lumina II imager, and the %
specific lysis was calculated as follows: [(minimum-test condition)/(minimum-maximum)]
x 100.
RMA vs RMA-S Tumor Challenges
For short-term tumor rejection assays, RMA and RMA-s cells were labeled with CFSE
and Cell Trace Violet respectively and injected i.v. at a 1:3 ratio into C57BL/6, cDKO
(NKp46iCre/WT) or NK-cell depleted C57BL/6 mice. For NK depletion, C57BL/6 mice were
i.p. injected with 200µg of anti-PK136 (NK1.1) 24 hours before tumor challenge. Animals
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were sacrificed 18 hours post tumor cell injection and the presence of splenic tumor cells
was determined by flow cytometry.

The ratio of RMA-s (CFSE+)/RMA (Cell Trace

Violet+) cells was calculated. For long-term tumor engraftment assays, 1 x 106 RMA or
RMA-s cells were subcutaneously injected into the left abdomen of C57BL/6, cDKO
(NKp46iCre/WT), or NK-cell depleted C57BL/6 mice. Tumors were left to grow for 11 days.
On Day 11, tumors were excised and weighed.
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